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The glutathione-mediated, retro Michael-type addition reaction is demonstrated to take 
place at the interface of water-soluble, maleimide-functionalized gold nanoparticles 
(Maleimide-AuNP). The retro Michael-type addition can be blocked by hydrolyzing the 
Michael addition thioether adduct at the nanoparticle’s interface. This procedure “locks” the 
molecule of interest onto the Maleimide-AuNP template, ensuring no loss of the molecular 
cargo from the nanocarrier. On the other hand, the glutathione-mediated retro Michael-type 
addition reaction can be exploited for delivering a molecular payload. The Michael donor, 4-
mercaptophenylacetic acid was modified with a terminal azide, allowing for addition of cargo 
through strain-promoted alkyne azide cycloadditions with various functional alkynes. The 
resulting AuNPs are versatile platforms for the integration of multiple functionalities within a 
single construct, enabling their use in complex biotic environments. As a proof of concept, a 
fluorogenic molecular cargo was incorporated onto a Maleimide-AuNP and delivered via the 
glutathione-mediated, retro Michael-type addition reaction. 
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Summary for Lay Audience 
Nanomaterials are extremely tiny materials that are typically between 1-100 nm in 
diameter and have unique characteristics and properties compared to the bulk material. They 
have been identified as promising candidates for application in optics, electronics, and 
medicine. Gold nanoparticles (AuNPs) are one type of nanomaterial that have been previously 
used in optical sensing, cancer therapy, and drug delivery due to their compatibility with 
biological environments and high stability. Flexible, linker chemicals attached to various 
functional molecules can be bound to the surface of AuNPs to change their physical and 
chemical properties. Further function (drug, imaging agent, etc.) can be introduced to AuNPs 
through the manipulation of the peripheral molecules using click reactions. Click chemistry, 
defined as highly efficient reactions that proceed under mild conditions, is becoming 
increasingly popular in the materials chemistry field due to its ease of purification and lack of 
undesired by-products. Previously our research group has demonstrated this reactivity by 
binding fluorescent molecules to AuNPs, then releasing them under biological conditions. The 
release was triggered by the addition of glutathione (GSH), a compound commonly found in 
cancer cells. Therefore, this research helped to develop a “click & release” system on AuNPs 
to deliver chemical cargo to GSH rich environments, however the system was poorly 
understood, and potential applications were largely unexplored. The goal of this thesis was to 
further investigate and improve this “click & release” system to expand its practicality and to 
widen the scope of its application. By implementing more bio-compatible click reactions in 
this system, a functional chemical cargo can be attached and released more effectively. The 
molecular system will be responsive towards GSH concentrations (which varies in tumor cells 
and healthy cells) and can therefore be exploited for selective release in biological 
environments. Overall, the goal of this research is to engineer functional and responsive 
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Chapter 1  
1 Introduction 
Over the past few decades, researchers have extensively studied nanotechnology 
and material sciences to synthesize a vast variety of nanomaterials, varying in morphology, 
solubility, and in size.1-2 These structurally unique materials are generally inert and difficult 
to functionalize; however, they can be specifically altered to become useful in several 
applications including drug delivery, biolabeling, and electrochemistry.3-4 Bioorthogonal 
click chemistry enables the facile introduction of functional moieties to nanomaterial 
surfaces. The incorporation of these transformations decreases reaction times, increases 
selectivity in complex environments, and provides greater molecular control when 
synthesizing functional nanomaterials for use in biological environments. To functionalize 
these materials, substituents with specific functions are conjugated to the nanomaterial 
surface or a reactive group is interfacially introduced, which can then be further 
functionalized. These functional moieties can then be displaced off the nanomaterial 
interface in the presence of glutathione, present in high concentrations in cancer cells.5 
Therefore, these bioorthogonal click reactions can be manipulated to develop a highly 
modular, multi-functional molecular system on nanomaterials for targeted biotic delivery 
of drugs, fluorophores, and redox active molecules.6  
Click chemistry has become an established category of reactions characterized by 
rapid, high yielding, and atom economic transformations that require minimal purification 
and can be carried out under ambient conditions.7 Click reactions tend to incorporate highly 
selective, reactive partners that make click chemistry very advantageous for complex 
chemical systems and a powerful tool in materials sciences.8-10 One of the most utilized 
click moieties in the field is the maleimide group. Maleimides are versatile compounds that 
can be easily modified using a wide range of click reactions, including Diels Alders 
(Scheme 1 A), Michael additions (Scheme 1 B), and 1,3-dipolar cycloadditions (Scheme 1 
C).11 This group is commonly tethered onto the periphery of materials to gain access to 
several routes of functionalization on a single template. As depicted in Scheme 1, multiple 
distinct transformations can install a single R group on the maleimide, allowing for several 
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different methods to incorporate the same functionality. Conversely, several different 
functionalities can be introduced to maleimides using only one click reaction: a Michael 
addition.  A Michael addition is a reaction where a nucleophile participates in a 1,4-
conjugate addition to an α, β-unsaturated carbonyl.12 The nucleophile is referred to as a 
Michael donor and can be derived from an anion or a heteroatom with a lone pair. The α, 
β-unsaturated carbonyl is the electrophile in the reaction and is referred to as a Michael 
acceptor.13 
 
Scheme 1: The introduction of a R group onto a maleimide through in multiple reactions; Diels Alder 
cycloaddition (A), thiol Michael addition (B), and a dipolar cycloaddition with an azide (C). 
Another set of transformations prominent in the field of click chemistry are alkyne-
azide cycloadditions (AACs) where an azide reacts with an alkyne to form a stable triazole 
ring (Scheme 2 A).14 However, this reaction is not a click reaction as high reaction 
temperatures are required. Although, with the use of copper (I) salts to catalyze this 
reaction, Sharpless and Meldal found that the cycloaddition occurs at r.t. (Scheme 2 B).15-
16 This click reaction was called the Cu(I)-assisted alkyne-azide cycloaddition (CuAAC). 
CuAACs enabled the construction of more advanced and complex structures that were 
previously difficult or impossible to obtain, however, its use in living systems was limited 
due to the cytotoxicity of Cu(I) that mediates the generation of reactive oxygen species 
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(ROS), which degrades delicate biomolecules.17-19 In 2004, Bertozzi and coworkers 
established a copper free AAC by utilizing strained alkynes (Scheme 2 C).20 These alkynes 
did not require catalysts for AACs because they were more reactive due to ring strain and 
bond angle deformation. With this new click reaction, named the strain-promoted alkyne-
azide cycloaddition (SPAAC), Bertozzi et al. demonstrated covalent modifications to 
biomolecules in living systems, overcoming the toxicity problem with CuAACs.20 
Therefore, SPAACs caught the attention of material scientists to be a viable chemical tool 
for the assembly of materials with more functional or complex architectures. This research 
is so impactful that it is a topic of discussion to be potentially awarded a Nobel Prize in 
Chemistry. 
 
Scheme 2: An azide participating in multiple reactions with alkynes; alkyne-azide cycloaddition (A), Cu(I)-
assisted alkyne-azide cycloaddition (B), and a strain promoted alkyne-azide cycloaddition (C). 
The successful implementation SPAACs with cyclooctyne (OCT) in biomaterials 
led to the development of improved or alternative strained alkynes. The objective of 
synthetic chemists is to design and yield strained alkynes with more rapid reaction kinetics 
than OCT by making the alkyne electron deficient and sterically rigid (Figure 1). The two 
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fluoro groups on difluorinated cyclooctyne (DIFO) are electron withdrawing, thus pulling 
electron density away from the alkyne and yielding a less stable, more reactive click partner 
for azides. Bicyclononyne (BCN) is a bicyclic compound with less steric encumbrance than 
OCT due to its substituent positioning being further from the strained alkyne. 
Dibenzoazacyclooctyne (DIBAC) and dibenzocyclooctyne (DIBO) introduced more sp2 
hybridized carbons into the cyclooctyne ring, causing more ring strain on the alkyne and 
blocking lower energy conformations from ring buckling. As the reaction kinetics of the 
strained alkynes improved, the stability of these derivatives decreased. To circumvent 
degradation and unwanted side reactivity of the strained alkyne, a cyclopropenone-masked 
dibenzocyclooctyne (hvDIBO) can be used. The Popik group was able to synthesize this 
molecule in 2009, and demonstrated the facile unmasking of the strained alkyne using 
ultraviolet A light.21 When hvDIBO is irradiated with 350 nm light, the cyclopropenone 
ring is opened and carbon monoxide is released via a radical process to cleanly yield the 
deprotected strained alkyne (Scheme 3). The rapid deprotection can be performed in situ 
and the resulting alkyne is then free to selectively react with an azide in a SPAAC. Along 
with its great stability and simple deprotection method, the application of hvDIBO in multi-
functional molecular systems introduces spatial and temporal control due to the sensitivity 
of the cyclopropenone group to 350 nm UV-A light.22-24 Electronically and sterically 
distinct azides have not been extensively studied due to the explosiveness of many small 
azides and expensive synthesis costs. However, one alternative to SPAACs are strain-
promoted alkyne-nitrone cycloadditions (SPANCs), where a strained alkyne and a nitrone 
combine to form a stable isooxazoline.25-27 
 
Figure 1: Various structurally unique, strained alkynes used in SPAACs. From left to right: cyclooctyne 






Scheme 3: The photochemical deprotection of hvDIBO via irradiation with 350 nm UV-A light. Carbon 
monoxide gas is liberated, yielding a strained alkyne which can form a triazole ring in a reaction with an 
azide. The cyclopropenone group of hvDIBO is unreactive in the presence of azides. 
Bioorthogonal reactions are a subset of click reactions, but with the added 
constraint of biocompatibility.28-31 These highly selective transformations can occur under 
physiological conditions (H2O, 37 °C, pH 6 – 8) and are inert in the presence of many other 
functional groups in biological systems.28 Bioorthogonal click reactions frequently involve 
organic azides as one of the click partners due to their small size, inert nature to many 
biological processes, and versatility (Figure 2).32-33 There are other moieties suitable for 
this class of reactions, but with nucleophiles, oxidants, and reductants so prevalent in living 
systems, these functionalities are quite rare. Despite these challenges, bioorthogonal click 
reactions have been extensively employed in a wide range of fields in chemical biology to 
form robust linkages.34-35 These transformations enable the facile introduction of functional 
moieties to biologically active nanomaterials as well.  
 
Figure 2: The stability of azides in physiological conditions (H2O, 37 °C, pH 6 – 8) in the presence of water, 
oxygen, enzymes, nucleophiles, oxidants, and reductants. 
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Nanomaterials are nanoscale materials that are typically between 1-100 nm in 
diameter and have unique properties and reactivity, compared to the bulk material.36 They 
have been identified as promising candidates for application in optics, electronics, and 
biomedicine.37-38 The properties of these nanomaterials utilized for their applications are 
largely determined by the material itself, which may depend on the size, morphology, and 
the functional groups at the interface of the material.39 In addition, nanomaterials provide 
a platform for the integration of multiple functionalities within a single construct, which 
permits their use in complex environments that require specific interactions at their 
interface. Manipulating the chemistry at the interface of these materials can alter the 
properties and allow them to be utilized in many applications; surface modifications have 
resulted in materials used in fluorescence imaging, drug delivery, and electrochemistry.40-
42 The Workentin Group has made efforts to incorporate SPAACs, along with other 
bioorthogonal click reactions into intricate molecular systems on gold nanoparticles 
(AuNPs) as a model reactive nanomaterial template to showcase chemical modifications 
in a facile and robust manner. AuNPs are one type of nanomaterial that have been 
previously used in optical sensing, cancer therapy, and drug delivery due to their 
biocompatibility and high stability.43-44 AuNPs are composed of a metallic gold core and 
an organic ligand corona that stabilizes the metal core and prevents aggregation of 
individual particles. Due to this stabilization, AuNPs are very stable and can be stored for 
long periods of time with minimal degradation.45 AuNPs have a strong binding affinity to 
thiols and their solubilities can be tuned to be organic or aqueous soluble (Scheme 4). These 
advantageous attributes of AuNPs can be controlled to engineer biocompatible 
nanoparticles; this is achieved by carefully selecting the thiol linker chains on the interface 
of the particles to be soluble in PBS buffer, by obtaining good particle stability at 37 °C, 
and by functioning at physiological pH.45 One can also control the size of AuNPs based on 
the nanoparticle synthetic method selected and the varying ratio of the concentrations of 
the gold salt to the thiol ligand.46 The high binding affinity between gold and sulfur allows 
for the conjugation of particles with organic ligands through thiol linker chains.47 These 
organic ligands can modify the interface of AuNPs with various functional groups in order 




Scheme 4: Tuning solubilities of hydroxyl-terminated AuNPs via place exchange reactions with varying 
quantities of the nonpolar ligand (red). Equilibria of bound stabilizing ligands to the metallic gold cores are 
established between the polar hydroxyl-terminated ligands (blue) and the nonpolar azide-terminated ligands 
to both give polar and nonpolar AuNP templates. These templates can be functionalized with strained alkynes 
to produce water soluble and organic soluble functional AuNPs.  
There are three main methods to add functionality onto AuNPs: direct synthesis, 
ligand displacement, and interfacial reactions. The direct synthesis method involves the 
addition of function to the particles during the initial synthesis of the particles (Scheme 5 
A), while the ligand displacement method introduces function to inert base AuNPs 
(Scheme 5 B). Base AuNPs are synthesized with non-functional thiolates that form a stable 
monolayer of tightly packed ligands and although these particles are inert, they can easily 
be functionalized via place exchange reactions. These reactions introduce a second thiol 
ligand but with functionality to the base AuNPs and the functional thiol displaces the inert 
ligands until an equilibrium is reached with different concentrations of the two ligands 
bound on the surface of the AuNPs.49 The third method is similar to the second, where inert 
base AuNPs are reacted with an additional thiol ligand in a place exchange reaction, but 
this thiol incorporates an intermediate reactive functionality (e.g. azides), not function 
(Scheme 5 C). The functionality is introduced during a second interfacial reaction, where 
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the functionality is bound to a reactive partner for the intermediate reactive functionality 
previously installed to combine with.50 Another great advantage of working with AuNPs 
is the ease of characterization, as these nanomaterials may be characterized with a wide 
range of powerful techniques, including: NMR, UV-Vis, IR, TGA, etc. Thus, AuNPs were 
chosen as a model nanomaterial to modify in this work because of their stability, 
biocompatibility, solubility, ease of synthesis and characterization. 
 
Scheme 5: Synthetic methods to introduce functionality (sun) to AuNPs; direct synthesis (A), ligand 
displacement (B), and interfacial reactions (C). 
 Previously, our group has demonstrated the use of Michael additions on maleimide-
terminated AuNPs with mercaptophenylacetic acid (MPA) derivatives. Our group 
demonstrated that in the presence of glutathione (GSH), MPA is able to undergo a retro-
Michael addition when bound to maleimide under physiological conditions (Scheme 6).51 
In this paper, a fluorescent dye was conjugated onto the carboxylic acid group of MPA as 
an imaging agent and the release of the dye in the presence of GSH and PBS buffer at 37 
°C was studied. This molecular system showed promise for a new complex, multi-
functional system on nanomaterial surfaces, however there were limitations. High 
temperatures were required to remove the furan groups off the protected maleimide-AuNPs 
via retro-Diels Alder reactions. Due to the increased temperatures, the desired AuNPs 
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began to aggregate, producing low yields and costly intermediate synthesis steps. The 
interfacial reactions on the resulting maleimide-AuNPs were time consuming and required 
several reagents that were difficult to separate from the desired AuNP products as well.  
 
Scheme 6: The manipulation of maleimide-terminated AuNPs. MPA (blue) is bound to the maleimides 
through Michael additions to yield the “unlocked” adduct. The “unlocked” adduct is then reacted with GSH, 
which displaced off MPA in a retro-Michael addition under physiological conditions. On the contrary, the 
“locked” adduct can be formed via hydrolysis of the maleimide of the “unlocked” adduct, which does not 
react with GSH to release MPA. 
Therefore, this thesis expands upon the previous system by utilizing more 
bioorthogonal click reactions and by incorporating 3-azido-1-propanamine onto the 
carboxylic acid moiety of MPA to form an amide that links to an azide. This modified 
MPA acts as a Michael donor and combines with maleimide and the azide can be used to 
introduce desired functionalization through SPAACs with strained alkynes. This new 
component opens the system up for facile, clean additions of various molecular cargo onto 
AuNPs with maleimide groups on the interface. Using SPAACs with azides to introduce 
functionality is much simpler than performing amide coupling reactions on carboxylic 
acids on the interface of AuNPs. As a result, this new molecular system is more adaptable 
to a versatile range of applications through cleaner transformations than the previous 
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system. Similarity, in the presence of GSH under physiological conditions, GSH can 
displace the cargo-loaded MPA groups off the MPA-maleimide-AuNPs to yield GSH-
maleimide-AuNPs and released free cargo. The aim of this work is to incorporate 
bioorthogonal click reactions to develop a multifunctional nanomaterial template, which 
can undergo SPAACs with various cargo loaded strained alkynes. This system will use 
thiol-Michael additions with an azide modified MPA derivative to reversibly functionalize 
the interface of the AuNPs. Consequently, synthesizing a single nanomaterial that can 
undergo an assortment of functionalization with strained alkyne derivatives generates a 
molecular system capable of participating in a wide scope of applications (Scheme 7). 
Some of the potential applications include fluorescence imaging agents, drug delivery 
systems, electrochemical catalysis, and more. By exploring the physical and chemical 
properties of a system such as this, we hope to expand the synthetic toolbox of material 
sciences. 
 
Scheme 7: A comparison between the previous molecular system and the versatile molecular system utilized 
in this work on AuNPs in order to develop a click and release system. MPA is depicted in blue, GSH is 






Chapter 2  
2 Small Molecule Studies 
2.1 AuNP Ligand Synthesis 
To begin this project, a plan was devised to synthesize thiol ligand (11); which 
incorporated the multi-functional system, in order to bind it onto the AuNP surface. The 
first reaction carried out was the furan protection of maleimide. This reaction was 
necessary to prevent Michael additions into maleimide by nucleophiles used in the next 
steps of the synthesis. After successfully isolating compound 1, a small amount of 3-
azidopropylamine (2) was prepared from (3-bromopropyl)ammonium bromide to be used 
later in the synthesis as an azide bound to a good nucleophile. This amine was used to 
modify the carboxylic acid group of MPA to add the clickable azide group to molecular 
system. Next, tetraethylene glycol was used as the starting compound for the synthesis of 
thiol 11. This molecule was chosen because the ether groups give better water solubility to 
the AuNPs it is bound to when compared to using a purely carbon chain like n-dodecane. 
Water solubility is extremely important for this project, as we want to utilize these particles 
in aqueous PBS buffer to mimic physiological conditions. The first modification to 
tetraethylene glycol was a ditosylation of the two hydroxyl groups at both ends of the chain. 
Then, one of the tosyl groups was substituted with a S-trityl group in a SN2 reaction using 
triphenylmethanethiol. The S-trityl group was used to install a protected thiol that can be 
easily deprotected at the end of the thiol 11 synthesis to yield the desired thiol. In this 
reaction, compound 4 was used in a large excess to statistically only substitute one end of 
the ligand with a S-trityl group. Next, the other tosyl group was substituted with the 
protected maleimide moiety to give compound 5 and then the product was refluxed in 
toluene to deprotect the maleimide group in a retro-Diels Alder reaction. 
The MPA portion of thiol 11 was then synthesized. First, the thiol of MPA was 
trityl protected to prevent dimerization from disulfide formation. The carboxylic group was 
then converted to an amide using compound 2 as the amine and HBTU as the coupling 
agent. This transformation covalently bound an azide useful in click reactions to MPA to 
yield compound 8. Then the molecule was subject to TFA and TIPS in CH2Cl2 to cleave 
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the trityl group off MPA. Immediately after purification, compound 9 was added to a 
solution of compound 6 in Ar(g) purged CH3OH to participate in a thiol-Michael addition 
and yield compound 10. Finally, thiol 11 was made by deprotecting the trityl group on 
compound 10 (Scheme 8).  
 
Scheme 8: Synthetic pathway to produce thiol 11 to be used to introduce an azide as a ligand on AuNPs. 
These azides will allow for the AuNPs to participate in interfacial SPAAC reactions. 
2.2 BCN Molecular Cargo Synthesis 
In the next phase of this project, several molecular cargoes covalently bound to 
bicyclononyne (BCN), a strained alkyne, were prepared. This process began by 
synthesizing BCN from cyclooctadiene (COD) and ethyl diazoacetate using a literature 
procedure developed by Dommerholt and coworkers (Scheme 9).53 In the first reaction 
step, COD and ethyl diazoacetate were reacted together to form a cyclopropane group off 
the eight membered ring by liberating nitrogen gas. This transformation was catalyzed with 
a rhodium catalyst to yield compound 12a/b as a regioisomeric mixture of 35:65 exo:endo. 
The two isomers were separated using column chromatography and only the isolated exo 
isomer was moved forward to the next synthetic step. Next, compound 12a was treated 
with LiAlH4 for 15 mins to reduce its ester to a primary alcohol and give compound 13. 
Then compound 13 was reacted with bromine in an alkene dibromination reaction and these 
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two newly installed bromo groups were added to function as good leaving groups in the 
next reaction. Potassium tert-butoxide was slowly added to a solution of compound 14 in 
dry THF, until all of 14 was converted to compound 15 in a double E2 reaction to yield the 
strained alkyne, BCN.  
 
Scheme 9: Synthetic pathway to synthesize a strained alkyne in BCN (15) and its modification with several 
different molecular cargoes to be utilized to deliver functionality to materials with an azide group through 
interfacial SPAAC reactions. 
After a bulk sample of BCN was accumulated, several different moieties that add 
functionality to the strained alkyne were attached to it (Scheme 9). First, a small portion of 
15 was converted to BCN-ferrocene 16 and reacted the rest with 4-nitrophenyl 
chloroformate to change the nucleophilic alcohol of BCN to an electrophilic carbonate 17. 
To conjugate BCN with a ferrocene group, 15 was stirred at r.t. with ferrocenecarboxylic 
acid, DCC, and DMAP in CH2Cl2 for 4 h. Compound 16 was a bright yellow solid that was 
synthesized to be used as a strained alkyne that delivers a redox active functionality to any 
material that it is reacted with. Next, the electrophilic BCN 17 was modified with 1-
pyrenemethylamine hydrochloride to form a stable amide and adhere the fluorescent 
pyrene group to the strained alkyne. Compound 18 is a white solid that fluoresces bright 
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blue light when under UV-visible light and this molecule can now deliver the ability to be 
used in applications such as fluorescence imaging to materials. Compound 20 was prepared 
following a previous literature procedure published by our group in 2015.54 This compound 
is a strained alkyne with a modified rhodamine B group attached. The compound is a shiny 
purple solid that fluoresces bright pink in solution when exposed to UV-visible light and 
can also be used to introduce fluorescent character 
2.3 hvDIBO Molecular Cargo Synthesis 
To demonstrate that BCN is not the only strained alkyne capable of delivering 
functionality to materials, another strained alkyne named photo-dibenzocyclooctyne 
(hvDIBO) was synthesized following a literature procedure outlined by Popik et al. in 
2014.55 The “photo” component of this compound arises from the cyclopropenone 
protecting group that masks the strain alkyne in order to prevent undesirable side reactions. 
This protecting group introduces an additional advantage in spatial and temporal control 
because the deprotection of the strained alkyne only required 350 nm light and light can be 
controlled to be focused into many different shapes and sizes. The first transformation in 
the synthesis of hvDIBO was a substitution reaction to replace a primary alcohol on 3-
methoxybenzyl alcohol with a bromo group (Scheme 10). Next, the product was treated 
with triphenylphosphine (PPh3) to yield a phosphonium salt as compound 22. Next, a 
Mitsunobu reaction was performed on 3-hydroxybenzaldehyde using 1-butanol to 
synthesize compound 23. Then, compound 22 was converted to an ylide with n-BuLi at – 
78 °C to give a Wittig reagent. Aldehyde 23 was added to a solution of the Wittig reagent 




Scheme 10: Synthetic pathway to synthesize an alternative strained alkyne to BCN as hvDIBO (29) and its 
modification with ferrocenecarboxylic acid to be utilized to deliver redox functionality to materials with an 
azide group through interfacial SPAAC reactions.  
Both isomers were suspended in a solution of Pd/C and EtOAc under an atmosphere of 
hydrogen gas in a hydrogenation reaction to give the alkane product 25. Then, sodium 
hydride and ethanethiol was used to cleave the methyl group of the alkane 25 to yield 
compound 26 with a hydroxyl group. The hydroxyl group was then TBDMS protected to 
remove all the acidic protons before the next transformation; a double Friedel-Crafts 
alkylation. In this step, compound 27 was reacted with tetrachlorocyclopropene and 
aluminum chloride followed by a hydrolysis to yield compound 28 as TBDMS-hvDIBO. 
To deprotect the TBDMS group, TBAF was added to a solution of compound 28 in THF 
and the reaction was stirred at r.t. for 30 mins, yielding hvDIBO 29. Before the photo-
deprotection of hvDIBO 29, the hydroxyl group was reacted with ferrocenecarboxylic acid, 
DCC, and DMAP in CH2Cl2 for 4 h to install a ferrocene group onto the compound. The 
product of this reaction (30) was then photo-deprotected by irradiating a solution of 
compound 30 with 350 nm light at r.t. for 10 mins to yield DIBO-ferrocene as a strained 
alkyne. This compound can be used as an alternative for compound 16 to deliver redox 
activity to materials containing azides. 
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2.4 Small Molecule Studies 
After the thiol ligand (11) containing the mutli-functional system and all the 
molecular cargoes were prepared, the project moved onto small molecule studies to 
determine the reaction conditions and parameters required to successfully carry out the 
interfacial reactions on AuNPs. These experiments were also conducted to obtain 1H NMR 
spectra of the molecular system with the molecular cargoes attached. These spectra were 
collected to be compared to the analogous system on the AuNPs. The comparison of the 
small molecule studies to the nanomaterial modifications aided in the analysis of the all the 
AuNP 1H NMR spectra. Signals in the 1H NMR spectra of AuNPs appear broad with 
minimal resolvable splitting patterns which renders complex molecules on particles 
difficult to analyze. The morphology of AuNPs are actually non-spherical, they are 
polyhedral in character in a face-centered cubic lattice with gold atoms occupying edges, 
terraces, and verticies.52-53 This characteristic causes the broadening of AuNP NMR spectra 
because the thiol ligands are bound to inequivalent gold atoms on the surface of the metal 
core. To conserve the amount of compound 6, N-methylmaleimide (NMM) was chosen as 
a substitute for the small molecule studies. The first step of these experiments was to 
monitor the thiol-Michael addition of compound 9 into NMM (Scheme 11). 
 
Scheme 11: Small molecule studies reacting the azide of adduct 32 with four strained alkynes carrying 
several molecular cargoes using SPAACs. These reactions were carried out to study the reaction conditions 
and parameters required to successfully carry out similar reactions on AuNPs. 
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The reagents were added to a round bottom flask and were stirred at r.t. in argon 
purged methanol to avoid disulfide formation. The Michael addition was complete after 
two hours to yield compound 32 as a white solid. The 1H NMR spectrum of this stable 
adduct displayed an interesting splitting pattern of the individual maleimide protons in the 
5-membered ring (Figure 3). Compound 32 was then reacted with each of the molecular 
cargoes separately using SPAACs to form stable triazole rings (Scheme 11). The first 
molecular cargo reacted with the adduct 32 was BCN-ferrocene 16. By simply adding 
compounds 32 and 16 into a vial with 1:1 CH2Cl2:CH3OH as the solvent and stirring at r.t. 
for 2 hours, product 33 is formed with minimal purification required. Similar conditions 
were used to yield compounds 34 and 35 by adding compounds 20 and 18, respectively. 
The 1H NMR spectra of compounds 33, 34, and 35 exhibited broadening of signals due to 
each of the products being regioisomeric mixtures that are not easily isolatable. The 
regioisomers are formed because in SPAACs, the azide can react with the strained alkyne 
in two different orientations to form the triazole ring. The last molecular cargo reacted with 
adduct 32 was DIBO-ferrocene 31. Some of the signals in the 1H NMR spectrum of product 
36 were duplicated. The reason for this change in the spectrum is also due to the product 
being a regioisomeric mixture, but the rigidity of DIBO helps to produce sharper signals 
than BCN, hence reducing the broadening (Figure 4). Thus, with the small molecules test 
reactions completed and all the molecular cargo successfully synthesized, the project 




Figure 3: 1H NMR spectrum of compound 32 with labelled chemical shifts, integrations, and characteristic 
proton assignments. The red, green, and purple circles represent the maleimide ring protons and each signal 
corresponds to a doublet of doublets. 
 
Figure 4: 1H NMR spectrum of compound 36 with labelled chemical shifts, integrations, and diagnostic 
proton assignments. The red, yellow, and purple circles represent the duplicated ferrocene protons. 
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2.5 Small Molecule Studies Experimental 
2.5.1 Materials and Methods 
All reagents, unless otherwise stated, were purchased from Sigma-Aldrich and used 
as received. All common solvents, triethylamine (Et3N), and trifluoroacetic acid (TFA) 
were purchased from Caledon. Ethanol (EtOH) was purchased from Commercial Alcohols. 
Dialysis membranes (MWCO 6000-8000 Da) were purchased from Spectra/Por. 
Glutathione was purchased from Alfa Aesar. 
1H and 13C{1H} NMR spectra were recorded on Varian INOVA 400 (or 600) or 
Bruker AvIII HD 400 spectrometers using CDCl3, CD2Cl2 or CD3OD as solvent. 
1H NMR 
spectra that were recorded in CDCl3 were referenced against residual protonated solvent at 
7.27 ppm. 13C NMR spectra that were run in CDCl3 were referenced to 77.00 ppm. NMR 
spectra are reported as follows: s (singlet), d (doublet), t (triplet), q (quartet), dd (doublet 
of doublets), dt (doublet of triplets), tt (triplet of triplets), m (multiplet), bs (broad signal). 
Coupling constants are reported as J values in Hertz (Hz). The number of protons for a 
given resonance is indicated as nH and is based on spectral integration values. FT-IR 
spectra were recorded using an attenuated total reflectance (ATR) attachment using a 
Bruker Vector 33 FT-IR spectrometer and using standard quartz cells (1 cm path length) 
with a scan range of 200 to 800 nm. Ultraviolet (UV)-visible spectra were recorded using 
a Varian Cary 300 Bio spectrometer. ESI MS spectra were recorded on a Micromass LCT 
mass spectrometer. Photolysis were conducted in a Luzchem LZC-4V photoreactor 







2.5.2 Preparation and Characterization of Compounds (1 – 36) 
2.5.2.1 Compounds 1 – 11 
 
Synthesis of Compound 1: 
To a pressure tube containing maleimide (0.500 g, 5.15 mmol) was added furan 
(0.526 mL, 7.73 mmol) and Et2O (25 mL). The tube was sealed and heated to 100 °C and 
stirred for 16 h. The pressure tube was then cooled to r.t. After, the precipitate was isolated 
using Buchner filtration and washed with cold Et2O (3 x 25 mL). The solid was then dried 
to afford compound 1 as a white solid (0.782 g, 92%). 1H NMR (CDCl3, 400 MHz): δ 7.92 
(bs, 1H), 6.52 (dd, J = 1 Hz, J = 1 Hz, 2H), 5.32 (dd, J = 1 Hz, J = 1 Hz, 2H), 2.89 (s, 2H). 
13C{1H} NMR (CDCl3, 101 MHz): δ 175.9, 136.7, 81.1, 48.9. FT-IR (ATR, ν, cm
-1): 3147, 
3067, 3012, 2998, 2751, 1771, 1717, 1704, 1700, 1695, 1683, 1675, 1652, 1398, 1288, 
1204, 1188, 1143, 1091, 1020, 937, 928, 906, 897, 855, 841, 822, 791, 734, 690, 636, 632, 
583. ESI-MS calcd for C8H7NO3
+ [M]+ 165.0426, found 165.0420; difference +3.64 ppm. 
Synthesis of Compound 2: 
To a flask containing (3-bromopropyl)ammonium bromide (1.64 g, 7.49 mmol) 
was added sodium azide (1.63 g, 25.0 mmol) and H2O (25 mL). The reaction mixture was 
refluxed at 100 °C and stirred for 16 h. The flask was then cooled to r.t. and Et2O (50 mL) 
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was added. After, the flask was placed in an ice bath and KOH (2.00 g, 89.1 mmol) in H2O 
(5 mL) was slowly added while stirring. The reaction mixture was then extracted with Et2O 
(3 x 30 mL) and the organic fraction was dried with K2CO3. The solid was then filtered out 
using gravity filtration was the excess solvent was removed to yield compound 2 (0.710 g, 
95%) as a clear colourless oil. 1H NMR (CDCl3, 400 MHz): δ 3.38 (t, J = 7 Hz, 2H), 2.81 
(t, J = 7 Hz, 2H), 1.73 (tt, J = 7 Hz, J = 7 Hz, 2H), 1.24 (bs, 2H). The 1H NMR spectrum 
corresponded with the literature.54 
Synthesis of Compound 3: 
To a flask containing tetraethylene glycol (10.0 g, 51.5 mmol) was added tosyl 
chloride (58.9 g, 309 mmol), Et3N (21.5 mL, 154 mmol), DMAP (1.26 g ,10.3 mmol), and 
CH2Cl2 (400 mL). The flask was stirred at r.t. for 16 h. The crude product was extracted 
with H2O (3 x 200 mL) and brine (50 mL), dried with MgSO4, and filtered using gravity 
filtration. After, the solvent was removed using rotary evaporation and the crude product 
was purified by column chromatography on silica gel using 3:1 EtOAc: hexanes as the 
eluent to afford compound 3 as a pale yellow oil (23.3 g, 90%). 1H NMR (CDCl3, 400 
MHz): δ 7.79 (d, J = 4 Hz, 4H), 7.33 (d, J = 4 Hz, 4H), 4.17 – 4.13 (m, 4H), 3.70 – 3.65 
(m, 4H), 3.59 – 3.52 (m, 8H), 2.44 (s, 6H). 13C{1H} NMR (CDCl3, 101 MHz): δ 144.9, 
133.1, 130.0, 128.1, 70.9, 70.7, 69.4, 68.8, 21.8. ESI-MS calcd for C22H30O9S2
+ [M]+ 
502.1331, found 502.1340; difference -1.75 ppm. 
Synthesis of Compound 4: 
To a flask containing compound 3 (12.1 g, 24.1 mmol) was added a mixture of 1:1 
EtOH: Benzene (100 mL) and was stirred at r.t. Then, NaOH (5.00 g, 12.0 mmol) and 
triphenylmethanethiol (3.33 g, 12.0 mmol) was dissolved in 1:1 EtOH: Benzene (40 mL) 
was slowly added to the reaction flask. The flask was stirred at r.t. for 24 h. Then, the 
solvent was removed, and the crude product was dissolved in CH2Cl2 (100 mL). The 
solution was filtered using gravity filtration and the CH2Cl2 was evaporated. The crude 
product was purified by column chromatography on silica gel using 1:1 EtOAc: hexanes 
as the eluent to afford compound 4 as a pale-yellow oil (4.02 g, 55%). 1H NMR (CDCl3, 
400 MHz): δ 7.79 (d, J = 4 Hz, 2H), 7.45 – 7.39 (m, 6H), 7.35 – 7.17 (m, 11H), 4.17 – 4.10 
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(m, 2H), 3.69 – 3.63 (m, 2H), 3.57 – 3.50 (m, 6H), 3.45 – 3.40 (m, 2H), 3.30 (t, J = 7 Hz, 
2H), 2.44 (s, 3H), 2.42 (t, J = 7 Hz, 2H). 13C{1H} NMR (CDCl3, 101 MHz): δ 145.0, 144.9, 
133.2, 130.0, 129.8, 128.1, 128.0, 126.8, 70.9, 70.7, 70.6, 70.3, 69.8, 69.4, 68.8, 66.7, 31.8, 
21.8. ESI-MS calcd for C34H38NaO6S2
+ [M+Na]+ 629.2008, found 629.2008; difference 
0.00 ppm. 
Synthesis of Compound 5: 
To a flask containing compound 4 (2.30 g, 3.79 mmol) was added compound 1 
(0.480 g, 2.92 mmol), K2CO3 (0.806, 5.83 mmol), and DMF (50 mL). The flask was stirred 
at 60 °C for 48 h. The volume was reduced, and the reaction mixture was dissolved in 
CH2Cl2 (50 mL). The crude product was extracted with H2O (3 x 200 mL) and brine (50 
mL), dried with MgSO4, and filtered using gravity filtration. After, the solvent was 
removed using rotary evaporation and the crude product was purified by column 
chromatography on silica gel using EtOAc as the eluent to afford compound 5 as a pale-
yellow oil (1.49 g, 85%). 1H NMR (CDCl3, 400 MHz): δ 7.44 – 7.38 (m, 6H), 7.31 – 7.17 
(m, 9H), 6.48 (s, 2H), 5.25 (s, 2H), 3.70 – 3.51 (m, 10H), 3.45 – 3.41 (m, 2H), 3.29 (t, J = 
7 Hz, 2H), 2.83 (s, 2H), 2.42 (t, J = 7 Hz, 2H). 13C{1H} NMR (CDCl3, 101 MHz): δ 176.2, 
145.0, 136.7, 129.8, 128.0, 126.8, 81.0, 70.7, 70.6, 70.3, 70.2, 69.8, 67.3, 66.7, 47.6, 38.3, 
31.8. FT-IR (ATR, ν, cm-1): 3059, 2923, 2096, 1780, 1706, 1652, 1541, 1490, 1444, 1397, 
1334, 1189, 1120, 746, 702. ESI-MS calcd for C35H37NNaO6S
+ [M+Na]+ 622.2239, found 
622.2216; difference +3.74 ppm. 
Synthesis of Compound 6: 
To a flask containing compound 5 (1.49 g, 2.48 mmol) was toluene (50 mL). The 
flask was stirred and refluxed at 110 °C for 16 h. After, the solvent was removed using 
rotary evaporation and the crude product was purified by column chromatography on silica 
gel using 1:1 EtOAc: hexanes as the eluent to afford compound 6 as a clear yellow oil (1.00 
g, 76%). 1H NMR (CDCl3, 400 MHz): δ 7.44 – 7.38 (m, 6H), 7.32 – 7.23 (m, 6H), 7.23 – 
7.17 (m, 3H), 6.67 (s, 2H), 3.75 – 3.67 (m, 2H), 3.45 – 3.41 (m, 2H), 3.30 (t, J = 7 Hz, 2H), 
2.42 (t, J = 7 Hz, 2H). 13C{1H} NMR (CDCl3, 101 MHz): δ 170.8, 145.0, 134.3, 129.8, 
128.0, 126.8, 70.7, 70.6, 70.3, 70.2, 69.8, 68.0, 66.7, 37.3, 31.8. FT-IR (ATR, ν, cm-1): 
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3464, 3055, 2867, 1958, 1710, 1706, 1704, 1700, 1695, 1683, 1652, 1594, 1489, 1443, 
1436, 1404, 1389, 1350, 1320, 1178, 1101, 1034, 1002, 972, 933, 888, 827, 767, 743, 695, 
677, 667, 635, 629, 622, 616, 576, 524, 506, 486, 472, 463, 458. ESI-MS calcd for 
C31H33NNaOsS
+ [M+Na]+ 531.2079, found 554.1972; difference +0.99 ppm. 
Synthesis of Compound 7: 
To a flask containing MPA (1.00 g, 5.94 mmol) was added trityl chloride (1.99 g, 
7.13 mmol), and Ar(g) purged CH2Cl2 (30 mL). The flask was stirred at r.t. under inert 
atmosphere for 2 h. After, the solvent was removed using rotary evaporation and the crude 
product was purified by column chromatography on silica gel using 7:1 CH2Cl2:acetone as 
the eluent to afford compound 7 as a yellow-white solid (2.22 g, 91%). 1H NMR (CDCl3, 
400 MHz): δ 7.43 – 7.37 (m, 6H), 7.26 – 7.15 (m, 9H), 6.91 (s, 4H), 3.51 (s, 2H). 13C{1H} 
NMR (CDCl3, 101 MHz): δ 176.1, 144.6, 134.8, 133.8, 132.9, 130.1, 129.2, 127.8, 126.8, 
70.9, 40.5. FT-IR (ATR, ν, cm-1): 3200-2500 (bs), 2900, 1700, 1594, 1485, 1441, 1298, 
1155, 1020, 946, 802, 767, 734, 694, 673, 654, 615, 532, 513, 467. ESI-MS calculated for 
C27H22O2S
+ [M+H]+ 410.1341, found 410.1338; difference +0.54 ppm. 
Synthesis of Compound 8: 
To a flask containing compound 7 (2.00 g, 4.87 mmol) was added compound 2 
(0.536 g, 5.35 mmol), HBTU (2.53 g, 6.67 mmol), DIPEA (1.73 g, 13.4 mmol), and 
CH3CN (100 mL). The flask was stirred at r.t. for 16 h. After, the solvent was removed 
using rotary evaporation and the crude product was purified by column chromatography 
on silica gel using 3:2 EtOAc: hexanes as the eluent to afford compound 8 as a white solid 
(1.99 g, 83%). 1H NMR (CDCl3, 400 MHz): δ 7.44 – 7.38 (m, 6H), 7.28 – 7.16 (m, 9H), 
6.98 – 6.84 (m, 4H), 5.34 (bs, 1H), 3.42 (s, 2H), 3.30 – 3.22 (m, 4H), 1.70 (tt, J = 7 Hz, J 
= 7 Hz, 2H). 13C{1H} NMR (CDCl3, 101 MHz): δ 170.9, 144.6, 135.0, 134.2, 134.1, 130.1, 
129.3, 127.8, 126.9, 71.1, 49.5, 43.5, 37.5, 28.8. FT-IR (ATR, ν, cm-1): 3271, 3054, 2897, 
2090, 1642, 1594, 1546, 1487, 1441, 1320, 1264, 1198, 1150, 1081, 1033, 1017, 838, 809, 
763, 740, 696, 620, 582, 528, 502, 428. ESI-MS calcd for C30H28N4NaOS
+ [M+Na]+ 
515.1882, found 515.1881; difference +0.11 ppm. 
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Synthesis of Compound 9: 
To a flask containing compound 8 (0.200 g, 0.406 mmol) was added CH2Cl2 (20 
mL). The flask was stirred at r.t. and purged with Ar(g) for 20 min in the dark. Then, TIPS 
(0.420 mL, 2.03 mmol) and TFA (0.620 mL, 8.12 mmol) were added to the reaction flask 
and the reaction mixture was stirred at r.t. for 2 h. After, the solvent was removed using 
rotary evaporation and the crude product was quickly purified by column chromatography 
on silica gel using 2:1 EtOAc: hexanes as the eluent. The product is a thiol, which are prone 
to disulfide formation in the presence of O2 (g). Therefore, the column must be run quickly 
and with Ar(g) purged eluent to afford compound 9 as a cloudy white oil (0.928 g, 91%). 
The product was stored in a vial purged with Ar(g) in the freezer. 
1H NMR (CDCl3, 400 
MHz): δ 7.29 – 7.25 (m, 2H), 7.15 – 7.11 (m, 2H), 5.72 (bs, 1H), 3.50 (s, 2H), 3.47 (s, 1H), 
3.33 – 3.26 (m, 4H), 1.72 (tt, J = 7 Hz, J = 7 Hz, 2H). 13C{1H} NMR (CDCl3, 101 MHz): 
δ 171.0, 132.3, 130.3, 130.2, 128.2, 49.7, 43,4, 37.7, 28.7. FT-IR (ATR, ν, cm-1): 3290, 
2931, 2888, 2555, 2088, 1644, 1594, 1538, 1491, 1438, 1416, 1402, 1337, 1294, 1239, 
1200, 1106, 1016, 956, 845, 800, 743, 676, 570, 493, 440. ESI-MS calcd for C11H14N4OS
+ 
[M]+ 250.0888, found 250.0896; difference -2.88 ppm. 
Synthesis of Compound 10: 
To a flask containing compound 6 (0.525 g, 0.989 mmol) was added CH3OH (30 
mL). The flask was stirred at r.t. and purged with Ar(g) for 20 min. Then, compound 9 
(0.225 g, 0.899 mmol) was added to the reaction flask and the reaction was stirred at r.t.  
and under inert atmosphere for 2 h. After, the solvent was removed using rotary 
evaporation and the crude product was purified by column chromatography on silica gel 
using 5% CH3OH in CH2Cl2 as the eluent to afford compound 10 as a pale yellow oil (0.344 
g, 49%). 1H NMR (CDCl3, 400 MHz): δ 7.51 – 7.47 (m, 2H), 7.43 – 7.38 (m, 6H), 7.31 – 
7.17 (m, 11H), 5.62 (bs, 1H), 4.01 (dd, J = 4 Hz, J = 9 Hz, 1H), 3.68 – 3.50 (m, 12H), 3.45 
– 3.40 (m, 2H), 3.32 – 3.26 (m, 6H), 3.13 (dd, J = 9 Hz, J = 13 Hz, 1H), 2.64 (dd, J = 4 Hz, 
J = 13 Hz, 1H), 2.42 (t, J = 7 Hz, 2H), 1.73 (tt, J = 7 Hz, J = 7 Hz, 2H). 13C{1H} NMR 
(CDCl3, 101 MHz): δ 175.6, 174.5, 170.5, 145.0, 136.2, 134.8, 130.5, 130.0, 129.8, 128.0, 
126.8, 70.7, 70.6, 70.3, 70.0, 69.8, 67.0, 66.8, 49.6, 44.0, 43.5, 38.4, 37.7, 36.2, 31.8, 28.7. 
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FT-IR (ATR, ν, cm-1): 3405, 3309, 3055, 2867, 2096, 1779, 1700, 1656, 1652, 1539, 1490, 
1443, 1394, 1349, 1332, 1265, 1189, 116, 1034, 1019, 768, 742, 700, 677, 667, 629, 622, 
616, 506. ESI-MS calcd for C42H47N5NaO6S2
+ [M+Na]+ 804.2866, found 804.2834; 
difference +3.88 ppm. 
Synthesis of Compound 11: 
To a flask containing compound 10 (0.140 g, 0.179 mmol) was added CH2Cl2 (20 
mL). The flask was stirred at r.t. and purged with Ar(g) for 20 min in the dark. Then, TIPS 
(0.183 mL, 0.895 mmol) and TFA (0.274 mL, 3.58 mmol) were added to the reaction flask 
and the reaction mixture was stirred at r.t. for 2 h. After, the solvent was removed using 
rotary evaporation and the crude product was quickly purified by column chromatography 
on silica gel using EtOAc as the eluent. The product is a thiol, which are prone to disulfide 
formation in the presence of O2 (g). Therefore, the column must be run quickly and with 
Ar(g) purged eluent to afford compound 11 as a pale-yellow oil (0.043 g, 45%). The product 
was stored in a vial purged with Ar(g) in the freezer. 
1H NMR (CDCl3, 400 MHz): δ 7.53 – 
7.49 (m, 2H), 7.27 – 7.22 (m, 2H), 5.62 (bs, 1H), 4.04 (dd, J = 4 Hz, J = 9 Hz, 1H), 3.68 – 
3.54 (m, 16H), 3.68 – 3.54 (m, 4H), 3.16 (dd, J = 9 Hz, J = 13 Hz, 1H), 2.72 – 2.62 (m, 
3H), 1.74 (tt, J = 7 Hz, J = 7 Hz, 2H), 1.59 (t, J = 8 Hz, 1H). 13C{1H} NMR (CDCl3, 101 
MHz): δ 175.6, 174.5, 170.6, 136.1, 134.8, 130.5, 130.2, 73.0, 70.7, 70.7, 70.4, 70.1, 67.1, 
49.7, 44.0, 43.5, 38.5, 37.8, 36.2, 28.7, 24.4. ESI-MS calcd for C23H34N5O6S2
+ [M+H]+ 






2.5.2.2 Compounds 12 – 20 
 
Synthesis of Compound 12a/b: 
To a flask containing Rh2(OAc)4 (0.776 g, 1.76 mmol) was added dry CH2Cl2 (20 
mL) and cyclooctadiene (40 mL, 330 mmol). In a separate flask containing ethyl 
diazoacetate (4.30 mL, 41.0 mmol) was added dry CH2Cl2 (20 mL) and was then added to 
the flask containing Rh2(OAc)4. The flask was stirred at r.t. for 48 h. After, the solvent was 
removed using rotary evaporation and the crude product was purified by column 
chromatography on silica gel using hexanes as the eluent to remove the excess 
cyclooctadiene. Then, the crude was purified again by column chromatography on silica 
gel using 0.5:9 EtOAc: hexanes as the eluent to separate the two isomers 12a (exo) and 
12b (endo) as clear, colourless oils (Total: 6.77 g, 85%, 35% exo and 65% endo). 1H NMR 
(CDCl3, 400 MHz): δ 5.68 – 5.60 (m, 2H), 4.10 (q, J = 7 Hz, 2H), 2.35 – 2.25 (m, 2H), 
2.25 – 2.14 (m, 2H), 2.14 – 2.03 (m, 2H), 1.62 – 1.41 (m, 4H), 1.25 (t, J = 7 Hz, 3H), 1.18 





Synthesis of Compound 13: 
A flask containing a suspension of LiAlH4 (0.862 g, 22.7 mmol) in dry Et2O (70 
mL) was cooled to 0 °C in an ice bath. To a separate flask containing compound 12a (5.80 
g, 29.9 mmol) was added dry Et2O (80 mL) and was also cooled to 0 °C. This solution was 
then added dropwise to the flask with LiAlH4. The flask was stirred at r.t. for 40 min and 
then cooled again to 0 °C. Then, H2O was added dropwise to the reaction flask until a white 
solid formed. The crude product was dried with Na2SO4, filtered using gravity filtration, 
and washed with cold Et2O (3 x 20 mL). After, the solvent was removed using rotary 
evaporation to afford compound 13 as a clear, colourless oil (3.80 g, 99%). 1H NMR 
(CDCl3, 400 MHz): δ 5.68 – 5.59 (m, 2H), 3.47 (d, J = 7 Hz, 2H), 2.35 – 2.23 (m, 2H), 
2.23 – 2.12 (m, 2H), 2.12 – 2.01 (m, 2H), 1.47 – 1.36 (m, 2H), 0.83 – 0.73 (m, 2H), 0.70 – 
0.62 (m, 1H). The 1H NMR spectrum corresponded with the literature.55 
Synthesis of Compound 14: 
To a flask containing compound 13 (3.70 g, 24.3 mmol) was added dry CH2Cl2 
(100 mL) and was also cooled to 0 °C. Then, bromine (1.60 mL, 31.6 mmol) was added to 
the flask dropwise until a yellow colour persisted in the flask. After, the reaction was 
quench with Na2S2O4 (aq) and it was added to the flask until the reaction mixture became 
colourless. The crude product was extracted with CH2Cl2 (3 x 20 mL) and brine (50 mL), 
dried with MgSO4, and filtered using gravity filtration. After, the solvent was removed 
using rotary evaporation to afford compound 14 as a white solid (7.21 g, 95%). 1H NMR 
(CDCl3, 400 MHz): δ 4.89 – 4.77 (m, 2H), 3.76 (d, J = 7 Hz, 2H), 2.76 – 2.61 (m, 2H), 
2.34 – 2.10 (m, 2H), 2.00 – 1.84 (m, 2H), 1.72 – 1.50 (m, 2H), 1.29 – 1.04 (m, 3H). The 
1H NMR spectrum corresponded with the literature.55 
Synthesis of Compound 15: 
To a flask containing compound 14 (7.00 g, 22.4 mmol) was added dry THF (100 
mL) and was cooled to 0 °C. Then, a 1.0 M solution of KOtBu in THF (74 mL, 73.9 mmol) 
was added dropwise to the flask at 0 °C. The flask was then stirred and refluxed at 70 °C 
for 2 h. Next, the flask was cooled to r.t. and quenched with NH4Cl (aq) (10 mL). The crude 
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product was extracted with CH2Cl2 (3 x 30 mL), dried with Na2SO4, and filtered using 
gravity filtration. After, the solvent was removed using rotary evaporation and the crude 
product was purified by column chromatography on silica gel using 3:1 Et2O:hexanes as 
the eluent to afford compound 15 as a white solid (1.75 g, 52%). 1H NMR (CDCl3, 400 
MHz): δ 3.73 (d, J = 7 Hz, 2H), 2.38 – 2.16 (m, 6H), 1.69 – 1.52 (m, 2H), 1.41 – 1.29 (m, 
1H), 1.00 – 0.87 (m, 2H). The 1H NMR spectrum corresponded with the literature.55 
Synthesis of Compound 16: 
To a flask containing ferrocenecarboxylic acid (0.577 g, 2.51 mmol) was added 
DCC (0.400 g, 1.93 mmol), DMAP (0.120 g, 0.965 mmol), and CH2Cl2 (40 mL). The flask 
was stirred at r.t. for 15 min. Then, compound 15 (0.290 g ,1.93 mmol) was added and the 
reaction mixture was stirred at r.t. for 4 h. The crude product was filtered using gravity 
filtration. After, the solvent was removed using rotary evaporation and the crude product 
was purified by column chromatography on silica gel using CH2Cl2 as the eluent to afford 
compound 16 as an orange solid (0.656 g, 90%). 1H NMR (CDCl3, 400 MHz): δ 4.82 (t, J 
= 2 Hz, 2H), 4.39 (t, J = 2 Hz, 2H), 4.30 (d, J = 8 Hz, 2H), 4.20 (s, 5H), 2.40 – 2.18 (m, 
6H), 1.76 – 1.60 (m, 2H), 1.54 – 1.44 (m, 1H), 1.07 – 0.97 (m, 2H). 13C{1H} NMR (CDCl3, 
101 MHz): δ 171.9, 98.9, 77.2, 71.6, 71.3, 70.3, 69.8, 62.3, 29.4, 21.6, 20.4, 17.8. FT-IR 
(ATR, ν, cm-1): 2911, 2809, 2064, 1696, 1467, 1373, 1346, 1275, 1135, 1054, 1022, 1001, 
943, 894, 815, 791, 776, 736, 670, 665, 559, 525, 478. ESI-MS calcd for 
C37H41N5NaO5SFe
+ [M+Na]+ 746.2094, found 746.2076; difference +2.47 ppm. UV-Vis 
in CH2Cl2 (max = 309, 348, 444 nm). 
Synthesis of Compound 17: 
To a flask containing compound 15 (0.700 g, 4.66 mmol) was added 4-nitrophenyl 
chloroformate (1.03 g, 5.13 mmol), pyridine (0.950 mL, 11.6 mmol), and CH2Cl2 (50 mL). 
The flask was stirred at r.t. for 20 min and then was quenched with NH4Cl (aq) (10 mL). 
The crude product was extracted with CH2Cl2 (3 x 20 mL) and brine (50 mL), dried with 
MgSO4, and filtered using gravity filtration. After, the solvent was removed using rotary 
evaporation and the crude product was purified by column chromatography on silica gel 
using 1:1 EtOAc: hexanes as the eluent to afford compound 17 as a white solid (1.05 g, 
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71%). 1H NMR (CDCl3, 400 MHz): δ 8.31 – 8.25 (m, 2H), 7.42 – 7.36 (m, 2H), 4.41 (d, J 
= 8 Hz, 2H), 2.41 – 2.19 (m, 6H), 1.69 – 1.45 (m, 3H), 1.12 – 1.01 (m, 2H). The 1H NMR 
spectrum corresponded with the literature.55 
Synthesis of Compound 18: 
To a flask containing compound 17 (0.075 g, 0.238 mmol) was added 1-
pyrenemethylamine hydrochloride (0.058 g, 0.216 mmol), Et3N (0.060 mL, 0.432 mmol), 
and DMF (5 mL). The flask was stirred at r.t. for 24 h. Then, the DMF was removed and 
the crude product was dissolved in Et2O (10 mL) and extracted with NaHCO3 (5 x 10 mL), 
dried with MgSO4, and filtered using gravity filtration. After, the solvent was removed 
using rotary evaporation and the crude product was purified by column chromatography 
on silica gel using 1:2 EtOAc: hexanes as the eluent to afford compound 18 as a white solid 
(0.061 g, 69%). 1H NMR (CDCl3, 400 MHz): δ 8.33 – 8.26 (m, 2H), 8.23 – 8.18 (m, 2H), 
8.18 – 8.12 (m, 2H), 8.10 – 7.95 (m, 4H), 5.10 (bs, 3H), 4.24 (d, J = 8 Hz, 2H), 2.33 – 2.10 
(m, 6H), 1.67 – 1.57 (m, 2H), 1.43 – 1.30 (m, 1H), 0.99 – 0.88 (m, 2H). 13C{1H} NMR 
(CDCl3, 101 MHz): δ 156.5, 131.4, 131.3, 131.2, 130.7, 128.2, 127.5, 127.4, 126.8, 126.1, 
125.4, 125.3, 125.1, 124.8, 124.7, 122.8, 122.7, 98.8, 63.1, 43.4, 29.1, 21.4, 20.2, 17.8. FT-
IR (ATR, ν, cm-1): 3302, 3092, 2939, 1773, 1702, 1699, 1695, 1684, 1675, 1652, 1604, 
1558, 1539, 1520, 1495, 1436, 1374, 1245, 1185, 1118, 1040, 954, 849, 817, 769, 732, 
694, 668, 584, 516, 472, 458. ESI-MS calcd for C28H25NO2
+ [M]+ 407.1885, found 
407.1884; difference +0.34 ppm. UV-Vis in CH2Cl2 (max = 300, 321, 323, 326, 334 nm). 
Synthesis of Compound 19: 
To a flask containing Rhodamine B (1.00 g, 2.10 mmol) was added DIPEA (0.420 
mL, 2.40 mmol), and CH2Cl2 (200 mL). Then, HBTU (0.910 g, 2.40 mmol) was added 
dropwise to the flask at 0 °C. The flask was stirred at 0 °C for 30 min and then monoBoc-
piperazine (0.450 g, 2.4 mmol) in CH3CN (20 mL) was added dropwise to the reaction 
flask. The flask was warmed to r.t. and then stirred for 16 h. After, the solvent was removed 
using rotary evaporation and the crude product was purified by column chromatography 
on silica gel using 15:1 CH2Cl2: EtOH 95% as the eluent. Next, to deprotect the piperazine 
moiety, the reaction mixture was dissolved in 10% TFA in CH2Cl2 (20 mL) and stirred at 
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r.t. for 2 h. After, the solvent was removed using rotary evaporation and the crude product 
was purified by column chromatography on silica gel using 3:1 CH2Cl2:EtOH 95% as the 
eluent to afford compound 19 as a shiny purple solid (1.21 g, 92%). 1H NMR (CDCl3, 400 
MHz): δ 7.71 – 7.62 (m, 2H), 7.60 – 7.55 (m, 1H), 7.35 – 7.30 (m, 1H), 7.21 (d, J = 8 Hz, 
2H), 6.94 (dd, J = 2 Hz, J = 9 Hz, 2H), 6.77 (d, J = 2 Hz, 2H), 3.69 – 3.51 (m, 12H), 2.89 
(bs, 4H), 1.32 – 1.29 (t, J = 7 Hz, 12H). The 1H NMR spectrum corresponded with the 
literature.56 
Synthesis of Compound 20: 
To a flask containing compound 17 (0.070 g, 0.218 mmol) was added compound 
19 (0.170 g, 0.272 mmol), DIPEA (0.129 mL, 0.741 mmol), and CH3CN (20 mL). The 
flask was stirred at r.t. for 20 h. After, the solvent was removed using rotary evaporation 
and the crude product was purified by column chromatography on silica gel using 7:3 
CH2Cl2:iPrOH as the eluent to afford compound 20 as a shiny purple solid (0.213 g, 84%). 
1H NMR (CDCl3, 400 MHz): δ 7.73 – 7.65 (m, 2H), 7.57 – 7.50 (m, 1H), 7.39 – 7.33 (m, 
1H), 7.31 – 7.17 (m, 2H), 7.09 – 6.67 (m, 4H), 4.14 (d, J = 8 Hz, 2H), 3.70 – 3.54 (m, 8H), 
3.36 (bs, 8H), 2.34 – 2.13 (m, 6H), 1.61 – 1.45 (m, 2H), 1.32 (t, J = 7 Hz, 12H), 0.99 – 0.89 









2.5.2.3 Compounds 21 – 31 
 
Synthesis of Compound 21: 
To a flask containing 3-methoxybenzyl alcohol (20.0 g, 145 mmol) was added 
CH2Cl2 (400 mL) and the flask was stirred at 0 °C for 10 min. Next, PBr3 (29.4 g, 109 
mmol) was added dropwise to the flask over 10 min. The flask was stirred at r.t.  for 40 
min and then quenched with NaHCO3 (aq) (50 mL). The crude product was extracted with 
Et2O (3 x 100 mL), Na2S2O3 (3 x 50 mL) and brine (50 mL). Then the organic fraction was 
dried with MgSO4 and filtered using gravity filtration. After, the solvent was removed 
using rotary evaporation to afford compound 21 as a colourless oil (26.7 g, 92%). 1H NMR 
(CDCl3, 400 MHz): δ 7.26 (t, J = 8 Hz, 1H), 7.00 – 6.96 (m, 1H), 6.95 – 6.92 (m, 1H), 6.86 
– 6.82 (m, 1H), 4.47 (s, 2H), 3.82 (s, 3H). The 1H NMR spectrum corresponded with the 
literature.57 
Synthesis of Compound 22: 
To a flask containing compound 21 (16.0 g, 79.6 mmol) was added PPh3 (59.5 g, 
227 mmol) and CH3CN (250 mL). The reaction mixture was refluxed at 80 °C and stirred 
for 2 h. The flask was then cooled to r.t. and the solvent was reduced using rotary 
evaporation. Toluene (500 mL) was then added to the flask to precipitate out the product 
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as a solid. The solid was collected using Buchner filtration and was washed with cold 
toluene (3 x 50 mL). After, the solid was dried to afford compound 22 as a white solid 
(35.9 g, 97%). 1H NMR (CDCl3, 400 MHz): δ 7.71 – 7.78 (m, 9H), 7.60 – 7.65 (m, 6H), 
6.99-7.03 (m, 1H), 6.74 – 6.78 (m, 2H), 6.63 – 6.65 (m, 1H), 5.36 – 5.33 (d, J = 12 Hz, 
1H), 3.53 (s, 3H). The 1H NMR spectrum corresponded with the literature.57 
Synthesis of Compound 23: 
To a flask containing 3-hydroxybenzaldehyde (12.0 g, 98.0 mmol) was added 1-
butanol (9.00 mL, 98.0 mmol), PPh3 (28.8 g, 98.0 mmol), and THF (200 mL). The flask 
was stirred at 0 °C and diisopropyl azodicarboxylate (19.9 g, 98.0 mmol) was added 
dropwise. The reaction mixture was stirred at r.t. for 30 min. After, the solvent was 
removed using rotary evaporation and the crude product was purified by column 
chromatography on silica gel using 1:10 EtOAc: hexanes as the eluent to afford compound 
23 as a colourless oil (11.4 g, 65%). 1H NMR (CDCl3, 400 MHz): δ 9.97 (s, 1H), 7.38 – 
7.44 (m, 3H), 4.00 – 4.04 (t, J = 7 Hz, 2H), 176 – 1.83 (m, 2H), 1.46 – 1.55 (m, 2H), 0.97 
– 1.01 (t, J = 7 Hz, 3H). The 1H NMR spectrum corresponded with the literature.57 
Synthesis of Compound 24a/b: 
To a flask containing compound 22 (22.0 g, 47.5 mmol) was added dry THF (300 
mL) and the mixture was stirred at – 78 °C (dry ice in acetone) for 15 min. The flask was 
purged with Ar(g) and a THF solution of nBuLi (5.05 mL, 54.6 mmol) was added dropwise 
at – 78 °C over 15 min. The reaction mixture was stirred at – 78 °C for 2 h. Next, compound 
23 (8.45 g, 47.5 mmol) in dry THF (20 mL) was added dropwise to the reaction flask. Then, 
the dry ice bath was removed, and the reaction flask was stirred at r.t. for 16 h. The reaction 
was quenched with H2O (50 mL) and the THF was removed using rotary evaporation. The 
crude product was extracted with EtOAc (3 x 100 mL) and brine (50 mL), dried with 
MgSO4, and filtered using gravity filtration. After, the solvent was removed using rotary 
evaporation and the crude product was purified by column chromatography on silica gel 
using 1:4 EtOAc: hexanes as the eluent to afford compounds 24a and 24b as colourless 
oils (10.2 g, 76%). 1H NMR (CDCl3, 400 MHz): δ 7.24 – 7.33 (m, 3H), 7.03 – 7.17 (m, 
6H), 6.78 – 6.86 (m, 5H), 6.71 – 6.75 (m, 1.5H), 6.57 (s, 2H), 3.99 – 4.02 (t, J = 7 Hz, 
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1.5H), 3.85 (s, 2H), 3.78 – 3.81 (t, J = 7 Hz, 2H), 3.66 (s, 3H), 1.75 – 1.82 (m, 2 H), 1.64 
– 1.71 (m, 2H), 1.38 – 1.57 (m, 3H), 0.92 – 1.01 (m, 5H). The 1H NMR spectrum 
corresponded with the literature.57 
Synthesis of Compound 25: 
To a flask containing compounds 24a and 24b (1.03 g, 3.64 mmol) was added 10% 
Pd/C (0.0388 g, 0.364 mmol) and dry EtOAc (100 mL). The flask was stirred at r.t.  and 
was purged with Ar(g) for 10 min. An outlet needle and a balloon of H2 (g) was attached to 
the flask using a metal needle. The metal needle was lowered into the solution in order to 
bubble H2 (g) throughout the reaction mixture. The flask was stirred at r.t. for 24 h and the 
balloon was refilled with H2 (g) after the first and second hours. Then, the reaction mixture 
was filtered over celite using gravity filtration. After, the solvent was removed using rotary 
evaporation and the crude product was purified by column chromatography on silica gel 
using 1:10 EtOAc: hexanes as the eluent to afford compound 25 as a colourless oil (0.942 
g, 91%). 1H NMR (CDCl3, 400 MHz): δ 7.16 – 7.23 (m, 2H), 6.73 – 6.80 (m, 6H), 3.91 – 
3.94 (t, J = 7 Hz, 2H), 3.77 (s, 3H), 2.88 (s, 4H), 1.72 – 1.79 (m, 2H), 1.44 – 1.56 (m, 2H), 
0.96 – 0.99 (t, J = 7 Hz, 3H). The 1H NMR spectrum corresponded with the literature.57 
Synthesis of Compound 26: 
To a flask containing compound 25 (2.80 g, 9.85 mmol) was added ethanethiol 
(6.05 mL, 79.0 mmol) and DMF (25 mL). The flask was stirred at 0 °C and a suspension 
of 60% NaH in oil (2.76 g, 69 mmol) was added dropwise to the reaction flask over 10 
min. The flask was stirred at r.t. for 30 min and then at 120 °C for 30 h. Then, the reaction 
flask was cooled to r.t., diluted with Et2O (100 mL), quenched with H2O (50 mL), and 
acidified by added 5% HCl (aq) (50 mL). The crude product was extracted with H2O (3 x 
100 mL) and brine (50 mL), dried with MgSO4, and filtered using gravity filtration. After, 
the solvent was removed using rotary evaporation and the crude product was purified by 
column chromatography on silica gel using 1:10 EtOAc: hexanes as the eluent to afford 
compound 26 as a colourless oil (2.40 g, 90%). 1H NMR (CDCl3, 400 MHz): δ 7.15 – 7.23 
(m, 2H), 6.75 – 6.80 (m, 4H), 6.68 – 6.69 (m, 2H), 4.93 (s, 1H), 3.94 – 3.97 (t, J = 7 Hz, 
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2H), 2.88 (s, 4H), 1.74 – 1.81 (m, 2H), 1.46 – 1.56 (m, 2H), 0.98 – 1.02 (t, J = 7 Hz, 3H). 
The 1H NMR spectrum corresponded with the literature.57 
Synthesis of Compound 27: 
To a flask containing compound 26 (2.10 g, 7.77 mmol) was added imidazole 
(0.582 g, 8.55 mmol), TBDMSCl (1.29 g, 8.55 mmol), and CH2Cl2 (50 mL). The flask was 
stirred at r.t. for 3 h and was then quenched with NH4Cl (aq) (5 mL). Then, the reaction 
mixture was diluted with Et2O (50 mL) and the organic layer was washed with H2O (3 x 
30 mL) and brine (50 mL). The organic fraction was dried with MgSO4 and filtered using 
gravity filtration. After, the solvent was removed using rotary evaporation and the crude 
product was purified by column chromatography on silica gel using 1:10 EtOAc: hexanes 
as the eluent to afford compound 27 as a colourless oil (2.77 g, 93%). 1H NMR (CDCl3, 
400 MHz): δ 7.13 – 7.22 (m, 2H), 6.74 – 6.82 (m, 4H), 6.68 – 6.71 (m, 2H), 3.93 – 3.97 (t, 
J = 7 Hz, 2H), 2.89 (s, 4H), 1.74 – 1.81 (m, 2H), 1.49 – 1.54 (m, 2H), 0.98 – 1.02 (m, 12H), 
0.20 (s, 6H). The 1H NMR spectrum corresponded with the literature.57 
Synthesis of Compound 28: 
To a flask containing aluminum chloride (0.900 g, 6.76 mmol) was added 
tetrachlorocyclopropene (1.20 g, 6.76 mmol) and CH2Cl2 (150 mL). The flask was stirred 
at r.t. for 20 min and then cooled to -78 °C. Then, a solution of compound 27 (2.60 g, 6.76 
mmol) in CH2Cl2 (20 mL) was added to the reaction flask and the flask was then stirred at 
-78 °C for 4 h. The flask was warmed to r.t. and stirred for 1 h before diluting with CH2Cl2 
(150 mL). Next, 5% HCl (aq) (100 mL) was added to the flask. The organic layer of the 
crude product was extracted with H2O (3 x 100 mL) and brine (50 mL), dried with MgSO4, 
and filtered using gravity filtration. After, the solvent was removed using rotary 
evaporation to afford compound 28 as a white solid (1.33 g, 45%). 1H NMR (CDCl3, 400 
MHz): δ 7.94 – 7.91 (d, J = 12 Hz, 1H), 7.89 – 7.87 (d, J= 8 Hz, 1H), 6.89 – 6.86 (m, 2H), 
6.83 – 6.81 (m, 2H), 4.05 – 4.02 (m, 2H), 3.36 – 3.26 (m, 2H), 2.63 – 2.57(m, 2H), 1.82 – 
1.75 (m, 2H), 1.55 – 1.46 (m, 2H), 1.03 – 0.97 (m, 12H), 0.25 (s, 6H). The 1H NMR 
spectrum corresponded with the literature.57 
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Synthesis of Compound 29: 
To a flask containing compound 28 (1.20 g, 2.75 mmol) was added 1M TBAF in 
THF (0.796 mL, 2.75 mmol) and THF (30 mL). The flask was stirred at r.t. for 30 min and 
was then quenched with NH4Cl (aq) (30 mL). The reaction mixture was diluted with CH2Cl2 
(100 mL) and the aqueous layer was extracted with CH2Cl2 (3 x 30 mL), dried with MgSO4, 
and filtered using gravity filtration. After, the solvent was removed using rotary 
evaporation and the crude product was purified by column chromatography on silica gel 
using 1:20 CH3OH: CH2Cl2 as the eluent to afford compound 29 as a white solid (0.846 g, 
96%). 1H NMR (DMSO, 400 MHz): δ 10.42 (s, 1H), 7.75 – 7.77 (d, J = 8 Hz, 1H), 7.68 – 
7.70 (d, J = 8 Hz, 1H), 7.08 (s, 1H), 6.98 – 7.01 (m, 1H), 6.89 – 6.90 (d, J = 4 Hz, 1H), 
6.82 – 6.84 (dd, J = 8 Hz, J = 4 Hz, 1H), 4.06 – 4.09 (t, J = 7 Hz, 2H), 3.34 – 3.44 (m, 2H), 
2.43 – 2.7 (m, 2H), 1.70 – 1.75 (m, 2H), 1.41 – 1.48 (m, 2H), 0.93 – 0.96 (t, J = 7 Hz, 3H). 
The 1H NMR spectrum corresponded with the literature.57 
Synthesis of Compound 30: 
To a flask containing compound 29 (0.0250 g, 0.0780 mmol) was added 
ferrocenecarboxylic acid (0.0230 g, 0.101 mmol), DCC (0.0160 g, 0.0780 mmol), DMAP 
(0.00477 g, 0.0390 mmol), and CH2Cl2 (10 mL). The flask was stirred at r.t. for 4 h. After, 
the solvent was removed using rotary evaporation and the crude product was purified by 
column chromatography on silica gel using 1:1 EtOAc: CH2Cl2 as the eluent to afford 
compound 30 as fluffy orange solid (0.0380 g, 93%). 1H NMR (CD2Cl2, 400 MHz): δ 8.07 
(d, J = 8 Hz, 1H), 7.98 (d, J = 8 Hz, 1H), 7.26 – 7.22 (m, 2H), 6.94 – 6.89 (m, 2H), 4.97 (t, 
J = 2 Hz, 2H), 4.54 (t, J = 2 Hz, 2H), 4.33 (s, 5H), 4.06 (t, J = 7 Hz, 2H), 3.46 – 3.35 (m, 
2H), 2.72 – 2.63 (m, 2H), 1.84 – 1.78 (m, 2H), 1.76 – 1.48 (m, 2H), 1.00 (t, J = 8 Hz, 3H). 
13C{1H} NMR (CD2Cl2, 101 MHz): δ 170.4, 163.0, 153.9, 148.7, 148.0, 136.5, 135.2, 
123.7, 121.8, 120.9, 116.7, 113.0, 72.9, 71.2, 70.6, 70.1, 68.7, 37.9, 37.4, 31.7, 30.2, 19.7, 
14.1. FT-IR (ATR, ν, cm-1): 3042, 2931, 2370, 1845, 1735, 1607, 1559, 1452, 1366, 1266, 
1229, 1218, 1154, 1128, 1089, 1016, 910, 828, 668, 538, 517, 502, 486, 472, 463, 458. 
ESI-MS calcd for C32H28FeO4
+ [M]+ 532.1337, found 532.1342; difference +0.86 ppm. 
UV-Vis in CH2Cl2 (max = 328, 345, 444 nm). 
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Synthesis of Compound 31: 
To a flask containing compound 30 (0.0200 g, 0.0376 mmol) was added CH2Cl2 
(20 mL). The reaction flask was stirred at r.t. while irradiating with 350 nm light for 10 
min. After, the solvent was removed using rotary evaporation to afford compound 31 as 
fluffy orange solid (0.0190 g, 100%). 1H NMR (CDCl3, 600 MHz): δ 7.32 (d, J = 12 Hz, 
1H), 7.24 (d, J = 12 Hz, 1H), 7.15 (d, J = 4 Hz, 1H), 7.07 (dd, J = 4 Hz, J = 12 Hz, 1H), 
6.90 (d, J = 4 Hz, 1H), 6.78 (dd, J = 4 Hz, J = 12 Hz, 1H), 4.97 (t, J = 3 Hz, 2H), 4.52 (t, J 
= 3 Hz, 2H), 4.32 (s, 5H), 3.99 (t, J = 4 Hz, 2H), 3.34 – 3.17 (m, 2H), 2.48 (d, J = 18 Hz, 
2H), 1.84 – 1.74 (m, 2H), 1.58 – 1.44 (m, 2H), 0.99 (t, J = 11 Hz, 3H). 13C{1H} NMR 
(CDCl3, 101 MHz): δ 170.5, 159.2, 155.4, 154.6, 150.1, 127.1, 126.6, 123.2, 122.0, 119.8, 
116.9, 115.5, 112.1, 112.1, 109.7, 72.2, 70.8, 70.1, 70.1, 68.0, 36.7, 36.6, 31.4, 19.4, 14.0. 
FT-IR (ATR, ν, cm-1): 3041, 2927, 2855, 2118, 1733, 1609, 1562, 1487, 1452, 1375, 1366, 
1298, 1257, 1218, 1178, 1144, 1109, 1083, 1026, 1018, 911, 823, 493. ESI-MS calcd for 
C31H28FeO3
+ [M]+ 504,1388, found 504,1393; difference -0.93 ppm. UV-Vis in CH2Cl2 











2.5.2.4 Compounds 32 – 36 
 
Synthesis of Compound 32: 
To a flask containing N-methylmaleimide (0.0200 g, 0.180 mmol) was added 
CH3OH (10 mL). The flask was stirred at r.t. and purged with Ar(g) for 20 min. Then, 
compound 6 (0.0450 g, 0.180 mmol) was added to the reaction flask and the reaction was 
stirred at r.t. and under inert atmosphere for 2 h. After, the solvent was removed using 
rotary evaporation and the crude product was purified by column chromatography on silica 
gel using 1:3 CH2Cl2: EtOAc as the eluent to afford compound 32 as a white solid (0.0460 
g, 71%). 1H NMR (CDCl3, 400 MHz): δ 7.52 – 7.48 (m, 2H), 7.25 – 7.22 (m, 2H), 5.56 
(bs, 1H), 4.01 (dd, J = 4 Hz, J = 9 Hz, 1H), 3.57 (s, 2H), 3.35 – 3.28 (m, 4H), 3.15 (dd, J = 
9 Hz, J = 19 Hz, 1H), 2.91 (s, 3H), 2.68 (dd, J = 4 Hz, J = 19 Hz, 1H), 1.75 (tt, J = 7 Hz, J 
= 7 Hz, 2H). 13C{1H} NMR (CDCl3, 101 MHz): δ 175.8, 174.6, 170.4, 136.4, 135.1, 130.5, 
129.8, 49.7, 44.1, 43.5, 37.8, 36.4, 28.7, 25.3. FT-IR (ATR, ν, cm-1): 3253, 3100, 2948, 
2102, 1776, 1689, 1630, 1554, 1491, 1436, 1386, 1281, 1198, 1143, 1062, 1015, 950, 807, 
774, 690, 577, 494. ESI-MS calcd for C16H19N5O3S
+ [M]+ 361.1209, found 361.1208; 





Synthesis of Compound 33: 
To a flask containing compound 32 (0.0190 g, 0.0529 mmol) was added compound 
16 (0.0200 g, 0.0529 mmol) and a 1:1 mixture of CH2Cl2:CH3OH (10 mL). The flask was 
stirred at r.t. for 2 h. After, the solvent was removed using rotary evaporation and the crude 
product was purified by column chromatography on silica gel using 1:9 CH3OH: EtOAc 
as the eluent to afford compound 33 as bright orange solid (0.0370 g, 95%). 1H NMR 
(CDCl3, 400 MHz): δ 7.56 – 7.43 (m, 2H), 7.33 – 7.21 (m, 2H), 6.02 (bs, 1H), 4.81 (bs, 
2H), 4.40 (bs, 2H), 4.36 – 4.25 (m, 2H), 4.25 – 4.14 (m, 6H), 4.02 (bs, 1H), 3.51 (bs, 2H), 
3.27 – 3.04 (m, 4H), 3.01 – 2.80 (m, 4H), 2.76 – 2.58 (m, 2H), 2.35 – 2.21 (m, 2H), 2.06 – 
1.91 (m, 2H), 1.76 – 1.50 (m, 3H), 1.45 – 1.29 (m, 2H), 1.18 – 1.01 (m, 2H). 13C{1H} NMR 
(CDCl3, 101 MHz): δ 175.8, 174.6, 171.9, 170.6, 136.5, 134.9, 130.4, 129.7, 71.5, 71.4, 
70.3, 70.3, 69.9, 62.0, 45.5, 44.3, 43.5, 36.8, 36.4, 29.8, 29.2, 26.2, 25.3, 23.3, 22.8, 22.4, 
20.2, 19.8, 17.9. FT-IR (ATR, ν, cm-1): 3350, 1700, 1543, 1434, 1375, 1276, 1135, 953, 
733, 694, 501. ESI-MS calcd for C16H19N5NaO3S
+ [M+Na]+ 746.2076, found 746.2094; 
difference -2.47 ppm. UV-Vis in CH2Cl2 (max = 312, 347, 447 nm). 
Synthesis of Compound 34: 
To a flask containing compound 32 (0.0220 g, 0.0599 mmol) was added compound 
20 (0.0400 g, 0.0499 mmol) and CH2Cl2 (10 mL). The flask was stirred at r.t. for 4 h. After, 
the solvent was removed using rotary evaporation and the crude product was purified by 
column chromatography on silica gel using 1:9 CH3OH: CH2Cl2 as the eluent to afford 
compound 34 as shiny purple solid (0.0520 g, 90%). 1H NMR (CDCl3, 400 MHz): δ 7.72 
– 7.64 (m, 2H), 7.58 – 7.54 (m, 1H), 7.46 – 7.36 (m, 4H), 7.36 – 7.30 (m, 1H), 7.26 – 7.22 
(m, 2H), 7.20 – 6.84 (m, 2H), 6.74 (bs, 2H), 4.42 – 4.24 (m, 2H), 4.02 – 3.96 (m, 1H), 3.37 
– 3.54 (m, 10H), 3.54 – 3.17 (m, 10H), 3.13 – 2.96 (m, 3H), 2.92 – 2.85 (m, 3H), 2.83 – 
2.74 (m, 1H), 2.72 – 2.58 (m, 2H), 2.14 (bs, 1H), 2.10 – 1.97 (m, 2H), 1.53 – 1.36 (m, 2H), 
1.36 – 1.27 (m, 12H), 1.23 – 1.12 (m, 2H), 1.11 – 0.95 (m, 2H). 13C{1H} NMR (CDCl3, 
101 MHz): δ 175.8, 174.7, 171.5, 167.7, 157.9, 157.9, 155.9, 155.8, 155.5, 144.7, 134.4, 
134.3, 132.3, 130.8, 130.4, 130.3, 130.2, 127.8, 114.3, 96.3, 64.2, 47.5, 46.3, 44.6, 42.8, 
41.9, 36.8, 36.6, 30.1, 26.2, 25.3, 23.2, 22.6, 20.5, 17.8, 12.8. FT-IR (ATR, ν, cm-1): 3447, 
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3054, 2970, 2968, 2369, 1738, 1698, 1646, 1589, 1558, 1466, 1414, 1395, 1380, 1366, 
1339, 1277, 1247, 1229, 1217, 1199, 1181, 1132, 1075, 1009, 922, 683. ESI-MS calcd for 
C59H70N9O7S
+ [M – CF3COO]
+ 1048.5113, found 1048.5102; difference +1.65 ppm. UV-
Vis in CH2Cl2 (max = 230, 250, 314, 443 nm). 
Synthesis of Compound 35: 
To a flask containing compound 32 (0.0200 g, 0.0540 mmol) was added compound 
18 (0.0200 g, 0.0491 mmol) and CH2Cl2 (10 mL). The flask was stirred at r.t. for 4 h. After, 
the solvent was removed using rotary evaporation and the crude product was purified by 
column chromatography on silica gel using 1:9 CH3OH: CH2Cl2 as the eluent to afford 
compound 35 as fine white powder (0.0370 g, 97%). 1H NMR (CDCl3, 400 MHz): δ 8.38 
– 8.27 (m, 1H), 8.24 – 8.19 (m, 2H), 8.19 – 8.13 (m, 2H), 8.11 – 7.97 (m, 4H), 7.49 – 7.42 
(m, 2H), 7.25 – 7.20 (m, 2H), 5.92 (bs, 1H), 5.18 (bs, 1H), 5.13 – 5.07 (m, 2H), 4.29 – 4.11 
(m, 4H), 4.00 – 3.91 (m, 1H), 3.49 (s, 2H), 3.22 – 3.01 (m, 4H), 2.93 – 2.75 (m, 5H), 2.75 
– 2.68 (m, 2H), 2.26 – 2.11 (m, 2H), 1.99 – 1.88 (m, 2H), 1.72 – 1.48 (m, 4H), 1.33 – 1.18 
(m, 2H), 1.10 – 0.92 (m, 2H). 13C{1H} NMR (CDCl3, 101 MHz): δ 175.8, 174.6, 170.6, 
156.6, 136.5, 134.9, 134.9, 133.1, 131.5, 131.4, 130.9, 130.4, 129.7, 128.3, 127.7, 127.5, 
127.0, 126.3, 125.6, 125.5, 125.2, 125.0, 124.9, 122.9, 63.0, 53.6, 45.4, 44.3, 43.6, 43.5, 
36.7, 36.4, 36.4, 29.1, 26.1, 25.2, 23.1, 22.7, 22.2, 20.1, 19.6, 17.9. FT-IR (ATR, ν, cm-1): 
3336, 3089, 2916, 2849, 2244, 1918, 1793, 1703, 1699, 1695, 1684, 1604, 1589, 1520, 
1506, 1472, 1456, 1436, 1418, 1366, 1311, 1053, 1026, 1002, 977, 967, 909, 846, 818, 
761, 729, 712, 682, 667, 647, 585, 555, 484, 463, 458. ESI-MS calcd for C44H44N6NaO5S
+ 
[M + Na]+ 791.2992, found 791.2994; difference -0.36 ppm. UV-Vis in CH2Cl2 (max = 
313, 321, 326, 349, 395 nm). 
Synthesis of Compound 36: 
To a flask containing compound 32 (0.0140 g, 0.0377 mmol) was added compound 
31 (0.0190 g, 0.0377 mmol) and CH2Cl2 (10 mL). The flask was stirred at r.t. for 4 h. After, 
the solvent was removed using rotary evaporation and the crude product was purified by 
column chromatography on silica gel using 5% CH3OH in EtOAc as the eluent to afford 
compound 36 as bright orange solid (0.0290 g, 90%). 1H NMR (CDCl3, 400 MHz): δ 7.66 
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– 7.33 (m, 4H), 7.33 – 6.96 (m, 2H), 6.92 – 6.67 (m, 2H), 5.89 (bs, 1H), 4.99 – 4.88 (m, 
2H), 4.56 – 4.45 (m, 2H), 4.45 – 4.31 (m, 2H), 4.31 – 4.24 (m, 5H), 4.12 – 3.86 (m, 3H), 
3.60 – 3.45 (m, 2H), 3.45 – 3.26 (m, 2H), 3.26 – 2.99 (m, 4H), 2.96 – 2.78 (m, 4H), 2.73 – 
2.58 (m, 1H), 2.16 – 1.85 (m, 2H), 1.83 – 1.58 (m, 2H), 1.58 – 1.40 (m, 2H), 1.02 – 0.91 
(m, 3H). 13C{1H} NMR (CDCl3, 101 MHz): δ 175.8, 174.6, 170.3, 170.3, 160.5, 159.1, 
151.9, 150.6, 143.5, 143.1, 139.3, 138.9, 136.4, 135.0, 134.9, 134.7, 133.2, 133.2, 130.5, 
130.5, 130.2, 130.2, 129.8, 127.4, 123.8, 123.7, 123.4, 123.3, 122.0, 120.3, 119.7, 117.8, 
116.6, 116.0, 113.2, 112.7, 72.3, 72.1, 70.8, 70.7, 70.1, 70.1, 69.7, 68.0, 67.7, 53.6, 49.6, 
46.1, 44.3, 43.6, 37.0, 36.9, 36.8, 36.5, 33.2, 33.2, 31.4, 31.4, 29.8, 29.7, 25.3, 19.4, 14.0. 
FT-IR (ATR, ν, cm-1): 3245, 3030, 2970, 1723, 1717, 1704, 1700, 1668, 1652, 1608, 1559, 
1516, 1490, 1455, 1436, 1375, 1366, 1270, 1229, 1217, 1205, 1156, 1110, 1019, 984, 955, 
918, 827, 761, 694, 668, 530, 516, 502, 486, 471, 462, 458. ESI-MS calcd for 
C47H48N5O6SFe
+ [M + C4H9O]
+ 866.2675, found 866.2642; difference +3.78 ppm. UV-Vis 





Chapter 3  
3 AuNP Synthesis & Interfacial Modifications 
3.1 AuNP Synthesis 
Moving onto working with AuNPs, inert, base AuNPs were synthesized using thiol 
39. This thiol was synthesized following a literature procedure and was chosen because it 
produces water soluble AuNPs that are highly stable (Scheme 12). These base AuNPs were 
also synthesized because the linear nature of thiol 39 allows for dense packing of the 
organic corona around the gold center, therefore increasing the stability of the AuNPs while 
maintaining good water solubility. The first transformation was a mono-tosylation of one 
of the hydroxyl groups of tetraethylene glycol to yield compound 37. Tetraethylene glycol 
was used in a great excess to prevent the formation of the ditosylated product. Next, 
potassium thioacetate participated in a SN2 reaction with the tosyl group of compound 37 
to produce compound 38. Then the thioacetate group was hydrolyzed to a thiol using NaOH 
in argon purged ethanol followed by 1 M hydrochloric acid to yield thiol 39. This thiol was 
stored in the freezer under an atmosphere of argon gas. To synthesize the AuNPs, the Brust-
Schiffrin method was used with NaBH4 as the reducing agent. This synthesis was followed 
from a paper our group has recently published and the procedure yields AuNPs with an 
average diameter of 2.9 ± 0.5 nm.59 Importantly, compound 40 was soluble in both polar 
organic and aqueous solvents. 
 
Scheme 12: Synthesis of AuNPs 41a/b following a literature procedure involving a Brust-Schiffrin particle 
synthesis and place exchange reaction.59 
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 Two different versions of compound 41 were synthesized by reacting compound 
40 with varying amounts of thiol 11 in this project. These reactions are called place-
exchange reactions and the AuNP products will have both thiols 11 and 39 bound to the 
colloidal gold core. The ratio of these thiols on the interface of the AuNPs are determined 
by an equilibrium of the thiol bound to the surface of the particles being displaced off by 
the introduced thiol and the reverse process as well. The alkyl portion added after the 
tetraethylene chain on thiol 11 makes it more nonpolar in character compared to thiol 39, 
making AuNPs with greater concentrations of 11 added more organic soluble (Scheme 13). 
 
Scheme 13: Tuning solubilities of hydroxyl-terminated AuNPs (40) via place exchange reactions with 
varying quantities of the nonpolar ligand 11 (red) to produce organic soluble (41a) and water soluble (41b) 
AuNPs. Equilibria of bound stabilizing ligands to the metallic gold cores are established between the polar 
hydroxyl-terminated ligands 39 (blue) and the nonpolar azide-terminated ligands to both give polar and 
nonpolar AuNP templates. These templates can be functionalized with strained alkynes to produce functional 
water soluble and functional organic soluble AuNPs.  
The thiol 11: particle 40 ratio used to produce AuNPs 41a was 1:1 by mass. These 
particles were synthesized to easily characterize the AuNPs because they are more soluble 
in organic solvents than AuNPs 41b and the 1H NMR signals for the azide terminated thiol 
ligand on AuNP 41a have greater intensity than for AuNP 41b due to the differences in the 
thiol ligand: particle ratio. The thiol 11: particle 40 ratio used to produce AuNPs 41b was 
1:6 by mass. These particles were synthesized because they are fully soluble in aqueous 
PBS buffer while the AuNPs 41a are only soluble in water with a little bit of methanol 
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added. Solubility in PBS buffer is critical for these particles because the glutathione release 
of MPA off the particles must be performed under physiological conditions. Therefore, 
AuNPs 41a are more organic soluble and were used to characterize the nanoparticles with 
NMR spectroscopy, while AuNPs 41b are soluble in PBS buffer and will be used in the 
glutathione release experiments. 
3.2 Organic Soluble AuNP Cargo Loading  
The organic soluble, azide-terminated AuNPs 41a synthesized in the last section 
were subjected to several different strained alkynes to participate in SPAACs, which 
introduced function (emissive and redox active compounds) to the AuNPs (Scheme 14). 
While the clicked products of these reactions were not treated with GSH under 
physiological conditions to trigger the release of the cargo, they were used to determine 
the efficiency and feasibility of the release experiments. This batch of AuNPs were not 
suitable for the release experiments because their poor solubility in aqueous solutions like 
PBS. However, the greater concentrations of the MPA containing ligand bound to the gold 
core on these AuNPs allowed for more resolved NMR spectra to be obtained. By 
comparing the NMR spectra of these functionalized AuNPs to those collected in Section 
2.4 of the clicked adducts, it was determined these reactions were clean and successful. 
These spectra were especially advantageous to examine as their polar, aqueous soluble 
analogs did not show resolved signals for the MPA containing ligands, due to their lower 
concentrations of these ligands at the interfaces. The four strained alkynes chosen were 
compounds 16, 18, 20, and 31. Compounds 16 and 31 were chosen because they contain 
ferrocene groups; redox active moieties that were monitored using cyclic voltammetry 
during the cargo release. Similarity, compounds 18 and 20 were picked for their emissive 
properties, that can be tracked by utilizing fluorescence spectroscopy. Compound 18 
included a pyrene group, a planar, neutral molecule that fluoresces bright blue and 
compound 20 included a rhodamine B group, a large, charged molecule that fluoresces a 
vivid pink colour. The strained alkyne present in compounds 16, 18, and 20 was BCN, 
while compound 31 incorporated DIBO instead to depict the versatility of this system. 
Unfortunately, due to time limitations involved with COVID 19, the depleted reserves of 




Scheme 14: Reaction schemes depicting versatile, organic soluble AuNPs (41a) participating in interfacial 
SPAACs with strained alkynes 16, 18, and 20 to produce functionalized AuNPs. The reaction between 41a 
and 31 was not performed due to limitations involved with COVID 19. 
Compound 42a was synthesized from a SPAAC of compounds 41a and 16. The 
dark brown colour of compound 41a was converted to a dark orange colour in the product 
42a due to the bright orange ferrocene groups covalently bound to the nanoparticle surface. 
The complex 1H NMR spectrum of compound 42a was analyzed with the help of the 1H 
NMR spectrum of compound 33, the small molecule analogue to the interface of compound 
42a. The comparison below shows that compound 16 was successfully attached onto the 
surface of the particles because all of the signals in the 1H NMR spectrum of compound 33 
were integrated into the 1H NMR spectrum of compound 41a, but broadened (Figure 5). 
The signal labelled with an orange circle corresponds to the methyl group on the maleimide 
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ring of compound 33. This signal is not present in the spectrum of compound 42a because 
it is replaced by ethylene glycol signals labelled with blue circles. All other signals are 
present in both spectra, indicating once again that compound 16 was successfully attached 
onto the surface of the particles. Similar NMR spectra comparisons and analysis were 
performed for AuNPs 44 and 45a to determine the outcomes of the interfacial SPAACs 
with strained alkynes 18 and 20, respectively. The complex 1H NMR spectra of AuNPs 44 
and 45a were analyzed with the assistance of the 1H NMR spectra of their small molecule 
analogues 35 and 34, respectively. As a result, the versatile, organic soluble AuNPs 41a 
were effectively conjugated with various cargo-loaded strained alkynes via SPAACs and 
the clicked products were characterized with 1H NMR spectroscopy to determine the 
effectiveness of the interfacial modifications.  
 
Figure 5: The comparison of the 1H NMR spectra of compounds 33 and 42a with labelled diagnostic proton 
assignments. The green, yellow, and purple circles represent the duplicated ferrocene protons. 
3.3 Interfacial Modifications of Water Soluble AuNPs 
The water soluble, azide-terminated AuNPs 41b synthesized in Section 3.1 were 
reacted with compounds 16 and 20 in SPAACs to yield AuNPs 42b and 45b, respectively 
(Scheme 15). Unfortunately, the water-soluble pyrene functionalized AuNPs were not 
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synthesized due to limitation involved with COVID 19. The pyrene starting material was 
ordered from Sigma Aldrich in July 2020, but the order was never fulfilled. As previously 
discussed, the 1H NMR spectra of the water-soluble AuNPs made in this section only 
cleanly show the tetraethylene signals due to the drastic difference in the proton 
integrations of this multiplet to all the other signals. The lower azide ligand concentrations 
on the AuNP gold cores are required to maintain their solubility in PBS for the release 
experiments. These spectra should have the same chemical shifts and multiplicity as the 1H 
NMR spectra of their organic soluble counterparts, but with different signal integrations. 
 
Scheme 15: Interfacial reactions to AuNP 41b to modify the physical and chemical properties of the 
nanoparticle surface via SPAACs with strained alkynes 16 and 20. Functionality was delivered to AuNP 41b 
using SPAACs and then the cargo was released using a solution of GSH under physiological conditions. If 
the maleimide ring is hydrolyzed, GSH triggered release does not occur and the payload is not delivered. 
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3.3.1 Electrochemical Studies 
After successfully synthesizing water-soluble, ferrocene (Fc) terminated AuNPs 
(42b), an experiment was designed to monitor the release of the Fc groups in 0.2M PBS 
for one week using cyclic voltammetry (CV). The original plan was to perform the release 
experiment with a bulk batch of AuNP 42b and collect equal aliquots at 0 h, 6 h, 12 h, 24h, 
48 h, 96 h, and 168 h. The aliquots would then be worked up separately and then prepared 
for cyclic voltammetry to measure the current as a function of potential over one week. 
While running a small-scale test reaction for this experiment, it was determined that this 
procedure was not feasible. The two main reasons for this conclusion were: 1) each sample 
for CV required approximately 10 milligrams of sample and 2) over the gradual release of 
the Fc groups, the surface chemistry of the AuNPs alter, leading to drastic differences in 
solubility between the aliquots.  The amount of AuNPs needed to collect seven CV plots 
(approx. 70 mg) was too costly, as these AuNPs require expensive starting materials and 
are time consuming to synthesize. The disparities in solubility between the aliquots arose 
as the Fc groups were being replaced by GSH on the nanomaterial interface throughout the 
length of the experiment (Scheme 16). This made it extremely difficult to isolate the AuNPs 
from the excess GSH, the released small molecules, and salts from the PBS in each aliquot. 
Furthermore, each aliquot required its own unique purification method, and it was not 
possible to determine these conditions with the limited quantities of AuNPs.  
 
Scheme 16: The changing solubility of water-soluble, Fc terminated AuNP 42b overtime as more nonpolar 
Fc (orange) groups are displaced by polar GSH (pink) groups. The AuNPs interface becomes gradually more 
water-soluble overtime creating difficultly in the purification steps of the reaction. 
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The plan quickly changed to performing the GSH mediated release on a smaller 
quantity of AuNP 42b without any aliquots taken, but instead thoroughly purifying the 
final product 43 after 1 week of release. The crude reaction mixture was extracted with a 
1:1 mixture of CH2Cl2: hexanes, Et2O, and a mixture of 1:1 CH3OH: hexanes to remove 
any organic, small molecules released off during the reaction. This washing procedure was 
repeated 5 times and the crude AuNPs were dissolved in CH3OH and centrifuged at 6000 
rpm for 10 min to remove insoluble solid impurities. The AuNPs were then further purified 
by overnight dialysis to remove any water-soluble salts from the PBS. Then, the sample 
was dried on high vacuum and passed onto Jonathan Wong from the Ding group to run and 
collect the CV plots (Figure 6). A three-electrode system was used with a glassy carbon 
working electrode and two platinum wires which served as the counter and reference 
electrode. The AuNP samples were dissolved at 3.13 mg/mL in anhydrous DCM and 
further purged with Ar(g) for 10 minutes. Tetrabutylammonium perchlorate (TBAP) was 
added into the electrochemical cell as the supporting electrolyte and all potentials were 
calibrated by an internal ferrocene standard taken at 0.424 V vs SCE.60-61  
 
Figure 6: Cyclic voltammetry plots for several water-soluble AuNPs to depict the GSH-mediated release of 
Fc groups off of AuNP 42b over 1 week. The current was measured as a function of potential. Azide 
terminated AuNPs (41b) were run for a baseline as there are no Fc groups present, Fc terminated AuNPs 
50 
 
(42b) for a time zero because no release has occurred yet, and finally the Fc terminated AuNPs (43) after 1 
week of GSH-mediated release were run. 
Three different AuNPs samples were run along with a blank: azide terminated 
AuNPs (41b) for a baseline as there are no Fc groups present, Fc terminated AuNPs (42b) 
as a time zero because no release has occurred yet, and finally the Fc terminated AuNPs 
(43) after a week of GSH-mediated release. The CV plots show the predicted results. The 
azide terminated AuNPs do not show any oxidation or reduction curves, due to the lack of 
redox active molecules in this potential range. The Fc terminated AuNPs exhibit oxidation 
and reduction waves corresponding to ferrocene-containing species. This data supports the 
successful attachment of Fc-BCN (16) onto AuNP 41b through a SPAAC as well. Finally, 
the plot for the AuNP 43, displays a CV curve with very small peaks corresponding to the 
remaining Fc groups bound to the gold core. By determining the difference in peak areas 
of the plots for AuNP 42b and 43, it was calculated that approximately 6% of the Fc groups 
present at t0 remain after a week of GSH-mediated release. Therefore, the release of redox 
active moieties on the surface of the Fc terminated AuNPs under physiological conditions 
works and almost all the releasable groups are displaced by GSH in one week. The gradual 
release of molecular cargo will be examined in the fluorescence studies.  
3.3.2 Fluorescence Spectroscopy 
In this section, water-soluble, rhodamine B terminated AuNPs 45b were reacted 
with GSH under physiological conditions to monitor the gradual release of emissive small 
molecules from the nanomaterial interface. This experiment exploited the property of 
AuNPs, where the fluorescence intensity of emissive molecules bound to its surface are 
partially quenched.62-63 It was predicted that overtime the fluorescence intensity would 
increase as GSH displaces off more and more rhodamine B groups as small molecules via 
retro-Michael additions. The unbound emissive groups cause the fluorescence count to 
increase, as the gold core can no longer quench the emission. The residual emission 
observed was utilized as a baseline of fluorescence for the timed, release experiments. The 
experiment involved stirring the reaction flask in PBS at 37 °C for seven days and 
collecting aliquots after 0 h, 6 h, 12 h, 24 h, 48 h, and 96 h to monitor the gradual release 
of the fluorescent cargo using fluorescence spectroscopy (Figure 7). Each aliquot was 
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diluted to 10 mL with 0.2M PBS before recording the fluorescence excitation (λex = 564 
nm) and emission spectra (λem = 585 nm). 
 
Figure 7: Fluorescence data depicting the gradual, GSH-mediated release of emissive, rhodamine B-
containing small molecules off AuNP 45b recorded over 96 h. All samples were run in 0.2 M PBS (pH = 
7.4) with excitation (left) and emission (right) wavelengths at 564 nm and 585 nm, respectively.  
 
Figure 8: Fluorescence data depicting the GSH-mediated release experiment on “locked” AuNP 47 recorded 
over 96 h. The fluorescence intensity is not expected to increase for this sample; however, the minimal release 
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of emissive molecules may be due to the incomplete hydrolysis of AuNP 45b and/or the dissociation of entire 
thiol ligands from unwanted place exchange reactions. All samples were run in 0.2M PBS (pH = 7.4) with 
excitation (left) and emission (right) wavelengths at 564 nm and 585 nm, respectively. 
The predicted, gradual increase of fluorescence was qualitatively and quantitively 
observed upon the addition of GSH in PBS to the AuNP sample, which corresponds to a 
greater concentration of free emissive dye, unbound from the nanoparticle interface. The 
fluorescence intensity was roughly quadrupled in 4 days of payload release. Although the 
release may appear steady overtime, it was seen that there was a gradual decrease in the 
fluorescence intensity difference between later aliquots within the timespan of this 
experiment. Another facet of this multi-functional molecular system is the ability to “lock” 
the maleimide groups on the AuNPs to prevent the GSH-mediated release of its cargo. The 
“locked” adduct can be formed via hydrolysis of the maleimide ring on the “unlocked” 
adduct with 0.5 M NaOH(aq.) at r.t. (Scheme 17). The resulting ring openings of the 
maleimides block the retro-Michael additions with GSH, leading to the retention of the 
nanoparticles’ covalently bound, emissive groups. After AuNP 45b was hydrolyzed to 
AuNP 47, the particles were subjected to the GSH-mediated release conditions for 5 days. 
The reaction progress was monitored with fluorescence spectroscopy, depicted on the 
previous page (Figure 8). 
 
Scheme 17: Reaction schemes describing to the synthesis of “unlocked” AuNPs 45b and “locked” AuNPs 
47 and the corresponding release experiments with GSH under physiological conditions to yield AuNPs 46 




The fluorescence data of the “locked” adduct 47 suggests there was partial release of the 
fluorophores bound to the nanoparticle interface. There are two hypotheses to explain this 
result, the incomplete hydrolysis of AuNP 45b and/or the dissociation of entire thiol 
ligands from unwanted place exchange reactions. The hydrolysis of AuNP 47 with 0.5 M 
NaOH(aq.) was only reacted for an hour, which may not have completely locked each of the 
maleimide rings, leading to accessible sites for GSH-mediated release of the MPA bound 
rhodamine B groups (Scheme 17). Place exchange reactions between GSH and the thiol 
ligands bound to the gold core are also possible, although unlikely due to the densely 
packed AuNP cores. In the chance that a rhodamine B terminated thiol is dissociated from 
the particles, an increase in fluorescence intensity may be detected. When comparing the 
fluorescence data for both the “locked” and “unlocked” adducts, it can be observed that the 
“locked” adduct displays a drastic decrease in fluorescence counts. In conclusion, the 
release of emissive cargo off both AuNPs 45b and 47 was monitored via fluorescence 
spectroscopy, resulting in gradual release for the “unlocked” AuNPs and blocked the 










3.4 AuNP Synthesis & Interfacial Modifications 
Experimental 
3.4.1 Materials and Methods 
All reagents, unless otherwise stated, were purchased from Sigma-Aldrich and used 
as received. All common solvents, triethylamine (Et3N), and trifluoroacetic acid (TFA) 
were purchased from Caledon. Ethanol (EtOH) was purchased from Commercial Alcohols. 
Dialysis membranes (MWCO 6000-8000 Da) were purchased from Spectra/Por. 
Glutathione was purchased from Alfa Aesar. 1H and 13C{1H} NMR spectra were recorded 
on Varian INOVA 400 (or 600) or Bruker AvIII HD 400 spectrometers using CDCl3, 
CD2Cl2 or CD3OD as solvent. 
1H NMR spectra that were recorded in CDCl3 were 
referenced against residual protonated solvent at 7.27 ppm. 13C NMR spectra that were run 
in CDCl3 were referenced to 77.00 ppm. NMR spectra are reported as follows: s (singlet), 
d (doublet), t (triplet), q (quartet), dd (doublet of doublets), dt (doublet of triplets), tt (triplet 
of triplets), m (multiplet), bs (broad signal). Coupling constants are reported as J values in 
Hertz (Hz). The number of protons for a given resonance is indicated as nH and is based 
on spectral integration values. FT-IR spectra were recorded using an attenuated total 
reflectance (ATR) attachment using a Bruker Vector 33 FT-IR spectrometer and using 
standard quartz cells (1 cm path length) with a scan range of 200 to 800 nm. Ultraviolet 
(UV)-visible spectra were recorded using a Varian Cary 300 Bio spectrometer. ESI MS 
spectra were recorded on a Micromass LCT mass spectrometer. Photolysis were conducted 
in a Luzchem LZC-4V photoreactor equipped with 14 UVA (350 nm) 8-watt lamps. 
Fluorescence spectroscopic studies were performed on a Photon Technology 
International (PTI) fluorimeter. Cyclic voltammetry of the AuNP samples were performed 
to probe the electrochemical features throughout the time release of ferrocene. A three-
electrode system was used with a glassy carbon working electrode and two platinum wires 
which served as the counter and reference electrode. The AuNPs were dissolved at 3.13 
mg/mL in anhydrous DCM and further purged with argon gas for 10 minutes. 
Tetrabutylammonium perchlorate (TBAP) was added into the electrochemical cell as the 
supporting electrolyte. All potentials are calibrated by an internal ferrocene standard taken 
at 0.424 V vs SCE.60-61 
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3.4.2 Preparation and Characterization of Compounds (37 – 48) 
3.4.2.1 Compounds 37 – 41 
 
Synthesis of Compound 37: 
To a flask containing tetraethylene glycol (26.0 g, 134 mmol) was added tosyl 
chloride (2.55 g, 13.4 mmol), Et3N (2.80 mL, 20.1 mmol), DMAP (0.122 g, 2.68 mmol), 
and CH2Cl2 (400 mL). The flask was stirred at r.t. for 16 h. The crude product was extracted 
with H2O (3 x 200 mL) and brine (50 mL), dried with MgSO4, and filtered using gravity 
filtration. After, the solvent was removed using rotary evaporation and the crude product 
was purified by column chromatography on silica gel using EtOAc as the eluent to afford 
compound 37 as a pale-yellow oil (4.38 g, 94%). 1H NMR (CDCl3, 400 MHz): δ 7.79 – 
7.76 (m, 2H), 7.34 – 7.30 (m, 2H), 4.17 – 4.12 (m, 2H), 3.71 – 3.55 (m, 14H), 2.44 (bs, 
1H), 2.43 (s, 3H). The 1H NMR spectrum corresponded with the literature.59 
Synthesis of Compound 38: 
To a flask containing compound 37 (9.25 g, 26.5 mmol) was added potassium 
thioacetate (2.94 g, 34.5 mmol) and acetone (400 mL). The flask was stirred at 50 °C for 
16 h. The crude product was extracted with CH2Cl2 (3 x 100 mL) and brine (50 mL), dried 
with MgSO4, and filtered using gravity filtration. After, the solvent was removed using 
rotary evaporation and the crude product was purified by column chromatography on silica 
gel using EtOAc as the eluent to afford compound 38 as a bright yellow oil (5.96 g, 89%). 
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1H NMR (CDCl3, 400 MHz): δ 3.75 – 3.57 (m, 14H), 3.10 (t, J = 7 Hz, 2H), 2.33 (s, 3H). 
The 1H NMR spectrum corresponded with the literature.59 
Synthesis of Compound 39: 
To a flask containing compound 38 (5.90 g, 23.4 mmol) was added CH3OH (150 
mL) and the flask was stirred at r.t. while purging with Ar(g) for 15 min. In a separate flask, 
1M NaOH in EtOH (50 mL) was also stirred at r.t. while purging with Ar(g) for 15 min. 
Then, the NaOH solution was added to the flask with compound 38 and the solution was 
stirred at r.t. for 45 min. Meanwhile, 1M HCl in H2O (120 mL) was stirred r.t. while 
purging with Ar(g) for 15 min. After 20 min of the 45 min had passed, the HCl solution was 
added to the reaction flask and the mixture was stirred for an additional 5 min. The crude 
product was extracted with CH2Cl2 (3 x 100 mL), dried with MgSO4, and filtered using 
gravity filtration. After, the solvent was removed using rotary evaporation and the crude 
product was quickly purified by column chromatography on silica gel using EtOAc as the 
eluent. The product is a thiol, which are prone to disulfide formation in the presence of O2 
(g). Therefore, the column must be run quickly and with Ar(g) purged eluent to afford 
compound 39 as a bright yellow oil (4.28 g, 87%). The product was stored in a vial purged 
with Ar(g) in the freezer. 
1H NMR (CDCl3, 400 MHz): δ 3.78 – 3.58 (m, 16H), 2.71 (dt, J = 
10 Hz, J = 12 Hz, 2H), 1.94 (bs, 2H), 1.62 (t, J = 12 Hz, 3H). The 1H NMR spectrum 
corresponded with the literature.59 
Synthesis of Compound 40: 
To a flask containing HAuCl4 ·3H2O (1.46 g, 3.70 mmol) was added a mixture of 
dry CH3OH (503 mL) and glacial acetic acid (83 mL). Next, compound 39 (2.30 g, 11.0 
mmol) was added to the flask. The solution was stirred at r.t. for 1 h. A solution of NaBH4 
(1.40 g, 37.0 mmol) in H2O (96 mL) was added dropwise to the reaction mixture while 
stirring. The mixture turned dark brown immediately. The flask was stirred at r.t. for 16 h 
and the solvent was removed using rotary evaporation. The resulting film of AuNPs was 
washed with toluene (30 mL) and the film was remade by dissolving the AuNPs in CH3OH 
(20 mL) followed by rotary evaporation to remove the solvent. This washing procedure 
was repeated 6 times. Next, the crude AuNPs were dissolved in H2O and centrifuged at 
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6000 rpm for 10 min to remove insoluble solid impurities. The crude AuNPs were then 
further purified by overnight dialysis. 1H NMR (CDCl3, 400 MHz): δ 4.17 – 2.87 (m, 16H). 
FT-IR (ATR, ν, cm-1): 3309, 1738, 1637, 1635, 1616, 1559, 1456, 1366, 1229, 1217, 1092, 
516. The 1H NMR spectrum corresponded with the literature.59 
Synthesis of Compound 41a (Nonpolar): 
To a flask containing compound 11 (0.0400 g, 0.0741 mmol) was added 1:1 dry 
CH2Cl2: dry CH3OH (4 mL) and the flask was purged with Ar(g) for 15 mins. Then, 
compound 40 (0.0400 g) in dry CH3OH (5 mL) was added to the reaction flask and stirred 
at r.t. for 16 h. After, solvents were removed by rotary evaporation to deposit a film of 
AuNPs inside a 100 mL round bottom flask. This film was washed with Et2O (30 mL) and 
the AuNP film was remade by dissolving in CH2Cl2 followed by rotary evaporation. This 
washing procedure was repeated 5 times and the crude AuNPs were dissolved in CH2Cl2 
(10 mL) and centrifuged at 6000 rpm for 10 min to remove insoluble solid impurities. The 
AuNPs were further purified by overnight dialysis to afford compound 41a as a dark brown 
film (0.055 g). 1H NMR (CDCl3, 400 MHz): δ 7.54 – 7.42 (m, 2H), 7.27 – 7.19 (m, 2H), 
4.13 – 4.02 (m, 1H), 3.85 – 3.48 (m, 22H), 3.35 – 3.24 (m, 4H), 3.24 – 3.10 (m, 1H), 2.71 
– 2.58 (m, 1H), 2.13 – 1.90 (bs, 3H), 1.81 – 1.67 (m, 2H). FT-IR (ATR, ν, cm-1): 3383, 
3030, 2924, 2900, 2370, 2096, 1776, 1703, 1699, 1684, 1656, 1652, 1645, 1635, 1559, 
1494, 1436, 1398, 1366, 1350, 1277, 1231, 1217, 1199, 1095, 517. 
Synthesis of Compound 41b (Polar): 
To a flask containing compound 11 (0.0100 g, 0.0185 mmol) was added 1:1 dry 
CH2Cl2: dry CH3OH (4 mL) and the flask was purged with Ar(g) for 15 mins. Then, 
compound 40 (0.0600 g) in dry CH3OH (5 mL) was added to the reaction flask and stirred 
at r.t. for 16 h. After, solvents were removed by rotary evaporation to deposit a film of 
AuNPs inside a 100 mL round bottom flask. This film was washed with Et2O (30 mL) and 
the AuNP film was remade by dissolving in CH3OH followed by rotary evaporation. This 
washing procedure was repeated 5 times and the crude AuNPs were dissolved in CH3OH 
(10 mL) and centrifuged at 6000 rpm for 10 min to remove insoluble solid impurities. The 
AuNPs were further purified by overnight dialysis to afford compound 41b as a dark brown 
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film (0.050 g). The 1H NMR spectrum for this compound only cleanly shows the 
tetraethylene signals due to the drastic difference in proton integrations of this multiplet to 
all the other signals. The spectrum should have the same chemical shifts and multiplicity 
as the 1H NMR spectrum of compound 41a, but different integrations. 





Synthesis of Compound 42a (Nonpolar): 
To a flask containing compound 16 (0.0150 g, 0.0397 mmol) was added 1:1 
CH2Cl2:CH3OH (4 mL) and the flask was stirred at r.t. for 15 mins. Then, compound 41a 
(0.0100 g) in CH3OH (5 mL) was added to the reaction flask and stirred at r.t. for 16 h. 
After, solvents were removed by rotary evaporation to deposit a film of AuNPs inside a 50 
mL round bottom flask. This film was washed with Et2O (30 mL) and a mixture of 1:1 
CH3OH: hexanes (30 mL) and the AuNP film was remade by dissolving in CH2Cl2 
followed by rotary evaporation. This washing procedure was repeated 5 times and the crude 
AuNPs were dissolved in CH2Cl2 (10 mL) and centrifuged at 6000 rpm for 10 min to 
remove insoluble solid impurities. The AuNPs were further purified by overnight dialysis 
to afford compound 42a as a yellowish-brown film (0.0130 g). 1H NMR (CDCl3, 400 
MHz): δ 7.52 – 7.34 (m, 2H), 7.31 – 7.21 (m, 2H), 4.81 (bs, 2H), 4.40 (bs, 2H), 4.36 – 4.16 
(m, 7H), 4.15 – 4.03 (m, 1H), 3.92 – 3.43 (m, 23H), 3.24 – 3.08 (m, 4H), 3.05 – 2.84 (m, 
1H), 2.73 – 2.58 (m, 1H), 2.39 – 2.21 (m, 2H), 2.06 – 1.91 (m, 2H), 1.72 – 1.55 (m, 2H), 
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1.45 – 1.31 (m, 1H), 1.21 – 0.97 (m, 2H). FT-IR (ATR, ν, cm-1): 3308, 1738, 1652, 1635, 
1616, 1559, 1539, 1506, 1456, 1366, 1229, 1217, 1092, 585. 
Synthesis of Compound 42b (Polar): 
To a flask containing compound 16 (0.0050 g, 0.0106 mmol) was added CH3OH 
(4 mL) and the flask was stirred at r.t. for 15 mins. Then, compound 41b (0.0250 g) in 
CH3OH (5 mL) was added to the reaction flask and stirred at r.t. for 16 h. After, solvents 
were removed by rotary evaporation to deposit a film of AuNPs inside a 50 mL round 
bottom flask. This film was washed with Et2O (30 mL) and CH2Cl2 (30 mL) and the AuNP 
film was remade by dissolving in CH3OH followed by rotary evaporation. This washing 
procedure was repeated 5 times and the crude AuNPs were dissolved in CH3OH (10 mL) 
and centrifuged at 6000 rpm for 10 min to remove insoluble solid impurities. The AuNPs 
were further purified by overnight dialysis to afford compound 42b as a yellowish-brown 
film (0.0250 g). The 1H NMR spectrum for this compound only cleanly shows the 
tetraethylene signals due to the drastic difference in proton integrations of this multiplet to 
all the other signals. The spectrum should have the same chemical shifts and multiplicity 
as the 1H NMR spectrum of compound 42a, but different integrations. 
Synthesis of Compound 43 (Polar): 
To a flask containing compound 42b (0.040 g) dissolved in 0.2M PBS (890 µL) 
was added a glutathione solution (0.00614 g in 56 µL of 0.2M PBS) and the flask was 
stirred at 37 °C for 7 days. The crude reaction mixture was extracted with a 1:1 mixture of 
CH2Cl2: hexanes (5 x 2 mL) and the excess solvent was removed by rotary evaporation to 
deposit a film of AuNPs inside the flask. This film was then washed with Et2O (30 mL) 
and a mixture of 1:1 CH3OH: hexanes and the AuNP film was remade by dissolving in 
CH2Cl2 followed by rotary evaporation. This washing procedure was repeated 5 times and 
the crude AuNPs was dissolved in CH3OH and centrifuged at 6000 rpm for 10 min to 
remove insoluble solid impurities. The AuNPs were then be further purified by overnight 
dialysis. The purified sample was dried to afford compound 43 (0.0090 g) as a dark brown 
film. The 1H NMR spectrum for this compound only cleanly shows the tetraethylene 
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signals due to the drastic difference in proton integrations of this multiplet to all the other 
signals. Compound 43 was characterized using cyclic voltammetry. 
Synthesis of Compound 44 (Nonpolar): 
To a flask containing compound 41a (0.010 g) was be added 1:1 CH2Cl2:CH3OH 
(4 mL) and the flask was stirred at r.t. for 15 mins. Then, compound 18 (0.015 g, 0.0368 
mmol) in CH2Cl2 (5 mL) was added to the reaction flask and was stirred at r.t. for 16 h. 
After, the solvent mixture was removed by rotary evaporation to deposit a film of AuNPs 
inside a 50 mL round bottom flask. This film was washed with Et2O (30 mL) and a mixture 
of 1:1 CH3OH: hexanes (30 mL) and the AuNP film was remade by dissolving in CH2Cl2 
followed by rotary evaporation. This washing procedure was repeated 5 times and the crude 
AuNPs were dissolved in CH2Cl2 (10 mL) and centrifuged at 6000 rpm for 10 min to 
remove insoluble solid impurities. The AuNPs were then further purified by overnight 
dialysis to afford compound 44 (0.0140 g) as a dark brown film. 1H NMR (CDCl3, 400 
MHz): δ 8.33 – 8.26 (m, 1H), 8.25 – 8.19 (m, 2H), 8.19 – 8.12 (m, 2H), 8.11 – 7.96 (m, 
4H), 7.56 – 7.40 (bs, 2H), 7.29 – 7.19 (bs, 12H), 6.48 – 5.89 (m, 7H), 5.81 (bs, 1H), 5.21 
(bs, 1H), 5.13 – 5.05 (m, 2H), 4.27 – 4.03 (m, 10H), 4.03 – 3.37 (m, 2H), 2.06 – 1.91 (m, 
111H), 3.37 – 3.23 (m, 20H), 3.23 – 2.97 (m, 14H), 2.94 – 2.75 (m, 6H), 2.73 – 2.50 (m, 
8H), 2.19 (bs, 3H), 1.99 – 1.45 (m, 30H), 1.09 – 0.91 (m, 3H). 
Synthesis of Compound 45a (Nonpolar): 
To a flask containing compound 20 (0.0150 g, 0.0187 mmol) was added 1:1 
CH2Cl2:CH3OH (4 mL) and the flask was stirred at r.t. for 15 mins. Then, compound 41a 
(0.0100 g) in CH3OH (5 mL) was be added to the reaction flask and stirred at r.t. for 16 h. 
After, excess solvents were removed by rotary evaporation to deposit a film of AuNPs 
inside a 50 mL round bottom flask. This film was washed with Et2O (30 mL) and a mixture 
of 1:1 CH3OH: hexanes (30 mL) and the AuNP film was remade by dissolving in CH2Cl2 
followed by rotary evaporation. This washing procedure was repeated 5 times and the crude 
AuNPs were dissolved in CH2Cl2 (10 mL) and centrifuged at 6000 rpm for 10 min to 
remove insoluble solid impurities. The AuNPs were further purified by dialysis for 3 days 
to afford compound 45a (0.0150 g) as a pinkish-brown film. 1H NMR (CDCl3, 400 MHz): 
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δ 7.70 – 7.56 (m, 3H), 7.56 – 7.45 (m, 2H), 7.33 – 7.23 (m, 3H), 7.20 – 7.09 (m, 2H), 6.90 
– 6.76 (m, 2H), 6.76 – 6.64 (m, 2H), 5.24 – 5.20 (m, 3H), 4.28 – 3.88 (m, 6H), 3.80 – 2.36 
(m, 75H), 2.27 – 1.79 (m, 8H), 1.59 – 1.30 (m, 4H), 1.30 – 0.53 (m, 24H). UV-Vis in PBS 
(max = 335, 532, 567 nm).  
Synthesis of Compound 45b (Polar): 
To a flask containing compound 20 (0.00667 g, 0.008324 mmol) was added 1:1 
CH2Cl2:CH3OH (4 mL) and the flask was stirred at r.t. for 15 mins. Then, compound 41b 
(0.0200 g) in CH3OH (5 mL) was be added to the reaction flask and stirred at r.t.  for 16 h. 
After, excess solvents were removed by rotary evaporation to deposit a film of AuNPs 
inside a 50 mL round bottom flask. This film was washed with a mixture of 1:1 CH2Cl2: 
hexanes (30 mL) and the AuNP film was remade by dissolving in CH3OH followed by 
rotary evaporation. This washing procedure was repeated 5 times and the crude AuNPs 
were dissolved in CH3OH (10 mL) and centrifuged at 6000 rpm for 10 min to remove 
insoluble solid impurities. The AuNPs were further purified by dialysis for 3 days to afford 
compound 45b (0.0225 g) as a pinkish-brown film. UV-Vis in PBS (max = 335, 532, 567 
nm). The 1H NMR spectrum for this compound only cleanly shows the tetraethylene 
signals due to the drastic difference in proton integrations of this multiplet to all the other 
signals. The spectrum should have the same chemical shifts and multiplicity as the 1H NMR 
spectrum of compound 45a, but different integrations. 
Synthesis of Compound 46 (Polar): 
To a flask containing compound 45b (0.0090 g) was added 0.2M PBS (460 µL) and 
the flask was sonicated to fully dissolve the AuNPs. A glutathione solution (0.00154 g in 
50 µL of 0.2M PBS) was added to the flask and it was stirred at 37 °C for 5 days. Aliquots 
(10 µL) were taken from the reaction flask after 0 h, 6 h, 12 h, 24 h, 48 h, and 96 h to 
monitor the release of the fluorescent cargo using fluorescence spectroscopy. Each aliquot 
was diluted to 10 mL with 0.2M PBS before recording the fluorescence excitation (λex = 
564 nm) and emission spectra (λem = 585 nm). Each sample of compound 46 will have 
different ratios of ligands on the surfaces of the AuNPs dependent on the time at which the 
aliquot was taken. UV-Vis in PBS (max = 335, 532, 567 nm). The 
1H NMR spectrum for 
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this compound only cleanly shows the tetraethylene signals due to the drastic difference in 
proton integrations of this multiplet to all the other signals. 
Synthesis of Compound 47 (Polar): 
 To a flask containing compound 45b (0.0066 g) was be added an aqueous 0.5M 
NaOH solution (1.65 mL) and the flask was stirred at r.t. for 1 h. The crude AuNP solution 
was then purified by overnight dialysis. The excess H2O was removed and the resulting 
AuNPs were dissolved in CH3OH (7 mL) and centrifuged at 6000 rpm for 10 min to remove 
insoluble solid impurities and afford compound 47 (0.0050 g) as a pinkish-brown film. 
UV-Vis in PBS (max = 335, 532, 567 nm). The 
1H NMR spectrum for this compound only 
cleanly shows the tetraethylene signals due to the drastic difference in proton integrations 
of this multiplet to all the other signals. 
Synthesis of Compound 48 (Polar): 
To a flask containing compound 47 (0.0050 g) was added 0.2M PBS (230 µL) and 
the flask was sonicated to fully dissolve the AuNPs. A glutathione solution (0.0077 g in 25 
µL of 0.2M PBS) was added to the flask and it was stirred at 37 °C for 5 days. Aliquots 
(10 µL) were taken from the reaction flask after 0 h, 6 h, 12 h, 24 h, 48 h, and 96 h to 
monitor the release of the fluorescent cargo using fluorescence spectroscopy. Each aliquot 
was diluted to 10 mL with 0.2M PBS before recording the fluorescence excitation (λex = 
564 nm) and emission spectra (λem = 585 nm). Each sample of compound 48 will have 
different ratios of ligands on the surfaces of the AuNPs dependent on the time at which the 
aliquot was taken. UV-Vis in PBS (max = 335, 532, 567 nm). The 
1H NMR spectrum for 
this compound only cleanly shows the tetraethylene signals due to the drastic difference in 





4 Conclusions & Future Work 
4.1 Conclusions 
Previously, work from our group demonstrated the use of bioorthogonal click 
reactions on maleimide-terminated AuNPs. It was shown that in the presence of GSH, 
MPA can undergo a retro-Michael addition when bound to a maleimide under 
physiological conditions. The release of a fluorescent dye directly bound the carboxylic 
acid group of MPA was studied and the molecular system showed promise for a new 
multifaceted, functional system on nanomaterial surfaces. This thesis expanded upon this 
work by incorporating 3-azido-1-propanamine onto the carboxylic acid group of 
MPA yielding an amide linked to an azide. The modified MPA acted as a Michael donor 
to combine with maleimides while, the azide introduced an array of functionalization 
through SPAACs with strained alkynes attached to the desired cargoes. 
In Chapter 2, all the small molecules required for the project were synthesized. A 
single azide terminated thiol ligand 11 was designed capable of reversible functionalization 
of AuNPs via Michael additions, SPAACs, and GSH-mediated releases. This ligand did 
not require an interfacial, retro-Diels Alder reaction to afford the reactive AuNP template, 
circumventing the loss of particles due to aggregation at high temperatures seen in the 
previous work from our group. Four different strained alkyne cargo were also made to 
introduce functionality onto the azide nanoparticles via SPAACs. Compounds 16 and 31 
were chosen because they contain ferrocene groups; redox active moieties that can be 
monitored using cyclic voltammetry during the release experiment. Compounds 18 and 20 
were picked for their emissive properties, that was tracked by utilizing fluorescence 
spectroscopy. In addition, the strained alkyne present in compounds 16, 18, and 20 was 
BCN, while compound 31 incorporated DIBO instead to depict the versatility of this 
system. This section also included test reactions to determine the reaction conditions of the 
SPAACs with compound 32 and to characterize the clicked products with 1H NMR 
spectroscopy to compare with their analogous AuNP counterparts in Chapter 3.  
 
In Chapter 3, two versions of the versatile, azide terminated AuNP template were 
synthesized. AuNPs 41a were more organic soluble and were used to characterize the 
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nanoparticles with 1H NMR spectroscopy, while AuNPs 41b were soluble in PBS buffer 
and were used in the glutathione release experiments. In the electrochemical studies, the 
redox active moieties were successfully released off from the surface of the Fc terminated 
AuNPs 42b under physiological conditions and determined that almost all the releasable 
groups are displaced by GSH in a week using cyclic voltammetry. In the fluorescence 
experiments, the release of emissive cargo off both AuNPs 45b and 47 was monitored via 
fluorescence spectroscopy, resulting in gradual release for the “unlocked” AuNPs and 
blocked the release for the “locked” adduct. 
 Therefore, the incorporation of bioorthogonal click reactions to develop a multi-
functional nanomaterial template was demonstrated, which can be loaded with various, 
functional cargo through SPAACs with strained alkynes. The system utilized thiol-Michael 
additions with an azide modified MPA derivative to reversibly functionalize the interface 
of the AuNPs. Consequently, a single nanomaterial that can undergo an assortment of 
functionalization with strained alkyne derivatives was synthesized, then the controlled 
release of desired functionalities was demonstrated in biotic environments using GSH in 
PBS. The slow release of the molecules generated a molecular system capable of 
participating in a wide scope of applications. Some of the potential 
applications include bio-labeling, drug delivery systems, electrochemical catalysis, and 
more. By continuing to explore the physical and chemical properties of a system such as 







4.2 Future Work 
The future of this project involves completing the experiments that were deferred 
due to the COVID 19 pandemic, before submitting for publication. These experiments 
include the interfacial studies with the pyrene strained alkyne, and monitoring the release 
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of this neutral, planar fluorophore off the AuNPs via fluorescence spectroscopy. The 
photochemistry and reactivity of hvDIBO cargo with the AuNPs will be examined as well. 
Thermal gravimetric analysis (TGA) will also be performed to characterize the ligand 
distributions on the organic and water-soluble AuNPs and determine the ligand to gold core 
mass percent difference. This versatile, molecular system may be implemented onto several 
different nanomaterial architectures as well, such as carbon nanotubes. 
Although I am finishing up my time at UWO for my MSc., I am returning to begin 
a cotutelle PhD program with UWO and the University of Bristol in January 2021. I was 
able to partially begin this work with the help of the Mitacs Globalink Research Award, 
which provided me with the opportunity to join the research group of Dr Pierangelo Gobbo 
at the School of Chemistry of the University of Bristol for three months in 2019. In my 
PhD, I will work to merge the field of functional nanomaterials with the field of bottom-
up synthetic biology and focus on the generation of protocellular materials from AuNP-
based colloidosome building blocks. We hope to develop the first inorganic protocellular 
materials that could be employed for applications in photothermal therapy, biosensing, and 
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Appendix 1: Supporting Information for Chapter 2 




Figure A1: 1H NMR spectrum of compound 1. 
 
Figure A2: {1H} 13C NMR spectrum of compound 1. 




Figure B1: 1H NMR spectrum of compound 3. 
 
Figure B2: {1H} 13C NMR spectrum of compound 3. 




Figure C1: 1H NMR spectrum of compound 4. 
 
Figure C2: {1H} 13C NMR spectrum of compound 4. 




Figure D1: 1H NMR spectrum of compound 5. 
 
Figure D2: {1H} 13C NMR spectrum of compound 5. 




Figure E1: 1H NMR spectrum of compound 6. 
 
Figure E2: {1H} 13C NMR spectrum of compound 6. 




Figure F1: 1H NMR spectrum of compound 7. 
 
Figure F2: {1H} 13C NMR spectrum of compound 7. 




Figure G1: 1H NMR spectrum of compound 8. 
 
Figure G2: {1H} 13C NMR spectrum of compound 8. 




Figure H1: 1H NMR spectrum of compound 9. 
 
Figure H2: {1H} 13C NMR spectrum of compound 9. 




Figure I1: 1H NMR spectrum of compound 10. 
 
Figure I2: {1H} 13C NMR spectrum of compound 10. 




Figure J1: 1H NMR spectrum of compound 11. 
 
Figure J2: {1H} 13C NMR spectrum of compound 11. 




Figure K1: 1H NMR spectrum of compound 16. 
 
Figure K2: {1H} 13C NMR spectrum of compound 16. 




Figure L1: 1H NMR spectrum of compound 18. 
 
Figure L2: {1H} 13C NMR spectrum of compound 18. 




Figure M1: 1H NMR spectrum of compound 30. 
 
Figure M2: {1H} 13C NMR spectrum of compound 30. 




Figure N1: 1H NMR spectrum of compound 31. 
 
Figure N2: {1H} 13C NMR spectrum of compound 31. 




Figure O1: 1H NMR spectrum of compound 32. 
 
Figure O2: {1H} 13C NMR spectrum of compound 32. 




Figure P1: 1H NMR spectrum of compound 33. 
 
Figure P2: {1H} 13C NMR spectrum of compound 33. 




Figure Q1: 1H NMR spectrum of compound 34. 
 
Figure Q2: {1H} 13C NMR spectrum of compound 34. 




Figure R1: 1H NMR spectrum of compound 35. 
 
Figure R2: {1H} 13C NMR spectrum of compound 35. 




Figure S1: 1H NMR spectrum of compound 36. 
 
Figure S2: {1H} 13C NMR spectrum of compound 36. 
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Appendix 2: Supporting Information for Chapter 3 
A. Characterization of Compound 41 
 
Figure T1: 1H NMR spectrum of compound 41. 
 




Figure U1: 1H NMR spectrum of compound 42. 
C. Characterization of Compound 44 
 
Figure V1: 1H NMR spectrum of compound 44. 
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